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The nuclear envelope is a complex double membrane system that separates 
the activities of the nuclear and cytoplasmic compartments.  A recent 
explosion in the number of proteins associated with this subnuclear organelle 
together with it now being linked to over 2 dozen diseases indicates the 
importance of better understanding its functional organisation. This thesis 
addresses two important questions for this: how do integral proteins of the 
nuclear envelope get to their sites of function and do any of these proteins 
direct genome organisation? To address the first question I used FRAP and 
photoactivation methods to find that different proteins use at least 4 distinct 
mechanisms to reach the inner nuclear membrane. Some appeared to be 
translocated by simple unaided lateral diffusion in the membrane while others 
needed Ran GTPase activity, others ATP, some others were aided by 
phenylalanine/glycines (FGs). Both Ran and FG mechanisms required the 
nucleoporin Nup35, albeit the mechanisms appeared to be completely 
independent of one another. To investigate the role of the nuclear envelope 
in genome organization, I screened for nuclear envelope proteins that 
reposition particular chromosomes to the nuclear periphery, finding five with 
this function. Interestingly, all of the proteins with this effect are tissue-
specific. Depletion of two liver-specific nuclear envelope proteins reversed 
their effects on a specific chromosome for positioning with respect to the 
nuclear periphery. Finally, exogenous expression of these proteins in tissue 
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Chapter 1  
Introduction 
1.1 The nuclear envelope architecture 
The Nuclear Envelope (NE) is the landmark that is used to distinguish 
eukaryotes from prokaryotes. It forms the physical barrier between the 
nucleus and the cytoplasm. Our ability to distinguish this feature emerged 
from advances in microscopy.  In 1931 the German physicist Ernst Ruska 
developed the electron microscope which revolutionized the field of cell 
biology as with the help of this device one was able to study cellular 
structures at a super magnification. So it was in 1950 that Callan and Tomlin 
performed electron microscopy on amphibian oocytes to reveal that the NE is 
a double membrane system (Callan and Tomlin, 1950). The 2 membranes, 
the outer (ONM) and inner nuclear membrane (INM), are connected at sites 
where the nuclear pore complexes (NPCs) are inserted (Figure 1). NPCs 
mediate directional transport between the cytoplasm and the nucleus for 
soluble molecules larger than ~40 kDa [reviewed in (D'Angelo and Hetzer, 
2006; D'Angelo and Hetzer, 2008)]. The ONM is continuous with the 
endoplasmic reticulum (ER) and is studded with ribosomes (Franke et al., 
1981; Gerace and Burke, 1988; Watson, 1955). Many proteins reside in both 
ONM and the ER; however there is evidence that some proteins localize 
uniquely to the ONM but not the ER [reviewed in (Schirmer and Foisner, 
2007)]. The ONM and INM are separated by a uniformly thick (30-50 nm) 
lumenal compartment, called the perinuclear space.  Some proteins that 
stretch from the ONM and the INM into the perinuclear space interact with 




nucleoplasm (Figure 1). The INM contains a unique set of membrane-
associated and integral proteins most of which have been identified only 
recently in several separate proteomic studies (Dreger et al., 2001; Korfali et 
al., 2010; Schirmer et al., 2003; Wilkie et al., 2011). Some of these specific 
INM proteins interact with the lamin polymer and with chromatin [reviewed in 
(Mattout-Drubezki and Gruenbaum, 2003)].  
Underlying the INM is the nuclear lamin polymer (Figure 1). The 
nuclear lamina is operationally defined as the intermediate filament lamin 
polymer together with those proteins integral to the membrane that resist 
biochemical extraction when the lipid membrane is removed with detergent 
(Dwyer and Blobel, 1976). Mutations in both lamins and several NE 
transmembrane proteins (NETs) cause a variety of human diseases, each 
with distinct and restricted tissue pathologies [reviewed in (Worman and 
Bonne, 2007)]. As the proteins linked to such diseases are widely expressed, 
it has been proposed that partner proteins with more restricted tissue 
distribution contribute to pathology (Schirmer and Gerace, 2005; Wilkie and 
Schirmer, 2006).  The loss of interaction between NE proteins and those 
partner proteins could result in aberrant signalling leading to gene 








Figure 1. Schematic of the nuclear envelope (NE). The NE consists of the 
outer (ONM) and inner (INM) nuclear membranes both of which are connected in 
spots where nuclear pore complexes (NPCs) are inserted. The NPCs regulate the 
nucleo-cytoplasmic transport of macromolecules. An intermediate polymer 
consisting of lamin proteins (blue) underlines the INM. The INM harbours a unique 
set of membrane proteins (NETs), which together with the lamin polymer are 
referred to as the lamina. Lamins, NETs and nucleoplasmic NPC proteins are known 
to interact with chromatin components such as histone proteins. (Figure adapted 
from Zuleger and Schirmer, 2011) 
 
 1.2 Trafficking of nuclear membrane proteins to the 
INM 
The transport of soluble cargos from the cytoplasm into the 
nucleoplasm has been extensively studied [reviewed in (Gorlich and Kutay, 
1999; Stewart, 2007)]. This process occurs through the central channel of the 
NPC and involves transport receptors termed karyopherins or importins 
which are interacting with both cargos and phenylalanine/glycine(FG)-
containing proteins of the NPC (nucleoporins). This process additionally 
involves the small GTPase Ran. Protein cargos containing a classical nuclear 
localization signal (NLS) are imported through the central channel of the NPC 
by the transport receptor importin-β, which binds the cargos through the 




with RanGTP resulting in dissociation of the import complex and release of 
the cargo. Importin-β and importin-α are recycled back to the cytoplasm 
separately both being bound to RanGTP. Once back in the cytoplasm 
RanGTPase is generating RanGDP resulting in dissociation of the importins 
making them available for a new import cycle.       
In contrast to soluble cargo transport, nuclear transport of nuclear 
envelope transmembrane proteins (NETs) remains less understood. The 
surface area of the nucleus doubles during interphase (Fry, 1976; Maul et al., 
1972; Steen and Lindmo, 1978), but the density of proteins in the nuclear 
membrane remains largely the same. For example, the distance between the 
NPCs essentially does not change because new NPCs are inserted into the 
membrane to match the growth of the membrane (D'Angelo et al., 2006; 
Maul et al., 1972). This means that NETs must be continuously synthesized 
in the ER and translocated into the INM via the NPC throughout interphase. 
But how does this happen? The nuclear membrane is continuous with the ER 
but covers the whole surface of the nucleoplasm, thus forming a diffusion 
barrier. However, the ONM and INM fuse with each other at the pore 
membrane where the NPCs are inserted (Prunuske and Ullman, 2006). 
Electron microscopy revealed that there are ~10nm peripheral channels 
between the NPC and the pore membrane (Hinshaw et al., 1992; Reichelt et 
al., 1990) that could allow NETs to move between the INM and ONM by 
simple lateral diffusion. These channels have been estimated to allow transit 









1.2.1 The lateral diffusion-retention mechanism 
The development of the diffusion-retention mechanism emerged from 
three key findings: 1) observations that viral transmembrane proteins could 
diffuse freely between ER/Golgi and INM (Torrisi et al., 1987), 2) the fact that 
an INM protein could move between nuclei in fused heterokaryons while 
protein synthesis was blocked (Powell and Burke, 1990) and 3) the discovery 
of peripheral channels between the NPC and the pore membrane (Hinshaw 
et al., 1992; Reichelt et al., 1990). The diffusion-retention hypothesis 
postulates that INM and ER proteins rapidly diffuse between INM and ER at 
equilibrium, but proteins of the INM are accumulated in the INM because of 
their ability to bind to lamins and/or chromatin (Figure 2). 
 
Figure 2. The lateral diffusion-retention hypothesis. After their synthesis in 
the ER, NETs translocate through the outer nuclear membrane (ONM) into the inner 
nuclear membrane (INM) using the peripheral channels of the nuclear pore 
complexes (NPCs). Diffusion can occur in both directions (ONM-to-INM or INM-to-
ONM) but directionality is achieved through interaction of NETs with nucleoplasmic 
components such as lamins and/or chromatin and NETs are thus retained in the 
INM. (Figure adapted and modified from Malik et al., 2009)  
 
It was Bruno Soullam and Howard Worman (Soullam and Worman, 




testing this hypothesis. They used fusion proteins of the INM protein lamin B 
receptor (LBR), so termed because of its ability to bind to lamin B (Worman 
et al., 1988). The aminoterminal domain of LBR that contains the lamin 
binding region (Ye and Worman, 1994) was fused to the transmembrane 
portion of the chicken hepatic leptin, a Type II transmembrane protein that 
resides normally in the ER and the plasma membrane (Chiacchia and 
Drickamer, 1984). After fusion, the chimeric protein accumulated in the INM 
meaning that the ER protein diffused between the INM and ONM but 
asymmetry in the diffusion equilibrium in favour of INM residency was 
achieved through binding of the LBR portion of the chimera to lamins in the 
nucleoplasm. This observation was confirmed by two further studies using 
lamin binding sequences from the INM proteins LAP2β (Furukawa et al., 
1998) and MAN1 (Wu et al., 2002). The retention part of the model was also 
supported by the fact that when performing FRAP on INM membrane 
proteins fused to GFP pre-bleach levels were never achieved after recovery 
of the fluorescence (Ellenberg et al., 1997; Rolls et al., 1999; Shimi et al., 
2004; Wu et al., 2002). This observation implied that a portion of the protein 
must be highly immobile due to interaction with nuclear components such as 
lamins or chromatin. Even stronger support for the retention-hypothesis came 
from observations that the INM protein emerin was more mobile in cells 









1.2.2 ATP and temperature dependence for INM 
translocation/ gated diffusion into the INM 
The Gerace laboratory demonstrated that translocation of their 
artificial construct (described below) was both ATP- and temperature-
dependent (Ohba et al., 2004). This opened the possibility that either the 
diffusion-retention mechanism is not as simple as previously thought or 
implied the observation of a completely novel mechanism for INM protein 
translocation.  
 In this study they cloned 2 portions (the transmembrane domain and 
the soluble lamin-binding domain) of the NET LAP2β and fused these 
portions with FRB and FKBP, respectively, both of which are interacting with 
each other when the drug rapamycin is present. The LAP2β membrane 
domain fused to FRB could freely diffuse between the ER and the INM as it 
did not contain the lamin and chromatin binding portion of LAP2β. The cells 
were then co-transfected with the soluble FKBP-fused LAP2β portion 
containing the lamin binding site. Upon addition of the drug rapamycin the 
FRB and FKBP fragments interacted and the transmembrane reporter 
accumulated rapidly in the INM due to the gained lamin binding ability. 
Further, the accumulation of this construct was strongly inhibited by reduction 
of temperature and depletion of ATP. Also, injected antibodies against the 
nucleoporin GP210 restricted INM accumulation of the construct, suggesting 
that the translocation process into the INM could also be NPC-dependent. 
This also raised the possibility that GP210 being a nucleoporin that localizes 
in the periphery of the NPC could act as a “gatekeeper”, which would allow 





Figure 3. ATP- and GP210-dependent translocation of INM proteins. After 
their biogenesis in the ER INM proteins are traversing through the peripheral 
channels of the NPC utilizing a mechanism that requires ATP and the presence of 
GP210. GP210 is likely to act as a “gate” that allows some molecules to pass but 
blocks others from translocation. (Adapted and modified from Malik et al., 2009) 
 
1.2.3 A classical NPC-mediated pathway 
The Summers laboratory found that viral and mammalian INM proteins 
are integrated into the membrane co-translationally and that viral and 
mammalian INM proteins occupy different sites at the translocon than other 
membrane proteins that are not destined for the INM. This suggested that the 
sorting of membrane proteins begins in the ER immediately after their 
synthesis (Braunagel et al., 2007). More importantly, they also found that 
importin-α-16/KPNA-4-16, an isoform of a nuclear import receptor protein, is 
interacting with the INM proteins already in the ER. Together with the findings 
of the Gerace laboratory that the nucleoporin protein GP210 was involved in 
INM targeting, this finding suggested a potential involvement of the NPC and 





The Blobel laboratory followed up on these findings and specifically 
tested for NPC function in INM protein transport (King et al., 2006). Using 
yeast as a model organism, the Blobel laboratory found that disruption of the 
Ran cycle inhibited the targeting of NLS-containing INM proteins Heh1 and 
Heh2 (human homologues are MAN1 and LEM2/NET25 respectively). The 
effect was reversible since restoring the Ran cycle resulted again in proper 
targeting of the proteins to the INM. Intriguingly, they also found that 
transport receptors, similar to the nuclear transport of soluble proteins, were 
involved in the targeting of Heh1 and Heh2. This was done by demonstrating 
that both importin-α and importin-β1 were responsible for the translocation of 
the NETs Heh1 and Heh2 as depletion of both receptors resulted in 
decreased localization in the INM of both NETs. Involvement of importin-α 
and importin-β1 seemed to be specific for these proteins as depletion of 
other known transport receptors had no effect on INM targeting of Heh1 and 
Heh2. Intriguingly, in vitro, a direct interaction between importin-α and Heh2 
was demonstrated whilst in vivo the transport was shown to be also NLS-
dependent, since a mutant version of Heh2 lacking the NLS failed to localize 
to the INM. 
 
 
Subsequently, the Kutay laboratory found in HeLa cells that the INM 
protein SUN2 also harbours an NLS and had the ability to bind importin-α 
and importin-β in vitro (Turgay et al., 2010). This finding further supported the 
presence of a classical NPC-mediated transport of INM proteins. However, 
unlike in the yeast study of Heh1 and Heh2, mutation of the SUN2 NLS did 
not inhibit the protein targeting to the INM, suggesting that SUN2 could use 
an alternative pathway independent from the one involving Ran and transport 
receptors.  
Additionally, the SUN2 study discovered another signal, a stretch of 
arginines that retrieved SUN2 from the Golgi-apparatus. Mutation of this 
Are NLSs really the determinants of the classical NPC translocation 




signal resulted in strong SUN2 accumulation in the Golgi. This added yet 




The involvement of classical nuclear transport components (transport 
receptors and Ran) reported in the Summers, Kutay and Blobel lab studies 
also opened room for speculation that instead of the peripheral NPC 
channels (as previously assumed) NETs could actually use the central NPC 
channels to translocate into the INM.   
A translocation of NETs through the central channel of the NPC would 
make sense from the point that there would be enough space in the central 
channel to accommodate transport receptors and Ran bound to the 
translocated protein. However, this scenario would most likely also involve an 
extraction of the NET from the membrane (Figure 4, B). Extraction would 
require a lot of energy and a complex system of proteins to both prevent 
aggregation of the hydrophobic membrane spans of the NET and to insert 
the NET after NPC transit (Figure 4, B).  
Translocation through the peripheral channel of the NPC would make 
more sense from the point of energy requirement since the NET would not 
have to be extracted from the membrane upon hydrolysis of ATP. However, if 
NETs really bind transport receptors to allow their translocation, the 
peripheral channels could not possibly accommodate this comparatively 
large receptor-NET complex. 
 
 






Figure 4. Speculative models of classical NPC-mediated transport of 
INM proteins. (A) After their synthesis in the ER NETs form a complex with 
transport receptor proteins (importins) and Ran, which is then traversing into the 
INM via the peripheral channels of the NPC. (B) After the biogenesis NETs are 
recognized by importins and Ran and are extracted from the lipid bi-layer with the 
help of chaperones to prevent aggregation of the membrane segments. The 
complex is then transiting into the nucleus through the central channel of the NPC. 
Once in the nucleus NETs are inserted into the INM. (Adapted and modified from 





The two most recent studies from the Starr and Veenhoff laboratories 
argue for a scenario that seems to be in-between the two described above. 
Analysing the yeast INM protein Heh2 (Meinema et al., 2011) and the 
drosophila INM protein UNC84 (Tapley et al., 2011) both studies suggest that 
the NETs remain in the membrane during transport with their C-terminal 
portion whereas the N-terminal portion perforates the central channel of the 
NPC where it binds to transport receptors and Ran (Figure 5). Even though 
both studies claimed the scenario of using the central channels, only the 
yeast study (Meinema et al., 2011) addressed this question through direct 
experiments. In this study they fused a central channel nucleoporin and their 
NET construct with FRB and FKBP, respectively, both of which bind to one 
another when the drug rapamycin is present. After addition of rapamycin the 
NET construct accumulated around the nuclear pores suggesting that it 
localized in the central channels. Unfortunately the study did not test the 
specificity of the system by testing if a peripheral channel nucleoporin, like 
Nup35 for example, would not be able to trap the translocating NET 
construct.  
The Drosophila study from the Starr laboratory additionally describes 
an INM sorting motif of UNC84 that is bound by the membrane associated 
truncated importin-α homologue (Figure 5), a mechanism that was earlier 





Figure 5. NET translocation through the central channel of the NPC. (1) 
After the synthesis in the ER NLS-containing NETs are recognized by importin-α-16, 
which localises the INM protein to the cytoplasmic face of the NPC. Here the 
transport receptors importin-α and importin-β are complementing the complex. (2) 
The transport receptor-bound soluble domain of the NET is then translocating 
through the central channel of the NPC while the membrane segment is retained at 
the membrane. (3) Once in the INM receptor proteins dissociate from the NET. 








1.2.4 Involvement of nucleoporins in targeting of INM 
proteins 
All mechanisms for transport of NETs into the INM described above 
have one thing in common: they all involve passage of the NET across the 
NPC. It is then not surprising that several studies found specific NPC 
proteins, or nucleoporins, to be involved in translocation of NETs into the 
INM. The earlier mentioned study from the Gerace laboratory found that 
injection of antibodies against the nucleoporin GP210 in HeLa cells blocked 
transport of the INM protein and that the effect was reversible when the 
GP210 peptides used for the generation of this antibody were introduced into 
the cells (Ohba et al., 2004). GP210 is considered to locate at the peripheral 
channel of the NPC and sticks into the lumen that is surrounded by the ONM 
and INM. Thus, it was proposed that GP210 might have a gating function for 
INM proteins when they diffuse into or out of the nucleus.  
Rick Wozniak’s laboratory made the observation that when another 
nucleoporin, Nup155, was depleted in HeLa cells, the targeting of tested 
inner INM proteins like LBR, LEM2 and LAP2β was strikingly impaired 
whereas the nuclear non-membrane protein lamin B was still targeting to the 
INM upon the Nup155 knockdown (Mitchell et al., 2010). Thus Nup155 
seemed to be an additional player that regulates transport of INM proteins.  
In other organisms nucleoporins were also shown to impact the import 
of NETs into the INM. Whilst in HeLa cells knockdown of GP210 and Nup155 
was inhibiting targeting of INM proteins, in Xenopus egg extracts depletion of 
another nucleoporin, Nup188, enhanced the translocation of NETs into the 
INM (Theerthagiri et al., 2010). Subsequent depletion of Nup188 was also 
shown to promote the passage of NETs into the INM in mammalian HeLa 
cells (Antonin et al., 2011). These findings suggested either a direct role for 
Nup188 to facilitate the passage of INM proteins along the NPC or that 
depletion of Nup188 destabilizes the NPC, potentially resulting in enlarged 




In yeast it was shown that two INM proteins, Heh1 and Heh2, required 
the NPC protein Nup2 but not Nup188 or Pom152 for translocation into the 
INM (King et al., 2006). But when the Hochstrasser lab analyzed the INM 
translocation requirements for another INM protein, Doa10, they found that 
Nup2 was not required but Nup188 and Pom152 were (Deng and 
Hochstrasser, 2006). This discrepancy strengthened the possibility that 
distinct mechanisms function for translocation of NETs to the INM. The 
distinct characteristics of different INM proteins are possibly the determinants 
that decide which pathway is utilized for transport into the nucleus. In fact this 
idea was supported by the fact that both Heh1 and Heh2 posses a classical 
NLS but Doa10 does not.  
While of course the nucleoporins mentioned above could really play a 
specific role in the transport of at least some NETs, the transport effects, both 
facilitation and inhibition upon manipulation of these Nups, could also be due 
to general disruption of the NPC. This scenario is very likely, because the 
NPC is a big complex and it is not difficult to imagine that depletion of some 
Nups, many of which are NPC core components [for review see (Lusk et al., 
2007)], from the NPC would actually destabilize the structure of this complex 
protein transport machine. Hence studies which manipulate Nups while 
testing if they are necessary for transport of NETs should also test for the 
specificity of the effect, for example by showing that transport of one protein 
is affected but another is not. Many of the studies described above were 
lacking these controls.   
 
 
Recent years have seen an explosion of players and mechanisms that 
could be involved in the targeting of NETs into the INM. It is, however, not 
clear if different independent mechanisms work in parallel or whether they 
are all part of a complex unifying mechanism. The existence of multiple 
mechanisms, for example, would enable essential NETs to reach the INM 




when a favoured mechanism is inhibited or overloaded. All studies described 
above were also only investigating one or two proteins, hence a reliable 
conclusion concerning the total pool of NETs and their requirement for a 
particular mechanism cannot be made. Clearly, a more systematic study 
sampling a large number of proteins under the same experimental conditions 
and testing for different requirements would resolve this question. 
In the last 20 years we have learned a lot about translocation of NETs 
into the INM but also several new key questions appeared, many of which 
will be addressed in this study. Discovering all the details of this translocation 
process is particularly important since improper targeting of many NETs has 














1.3 Genome organization from the NE? 
Once the NETs are in the INM they orchestrate several crucial cellular 
functions one of which is the organization of chromatin. Thus the second part 
of my thesis will deal with NET-mediated spatial genome organization.  
 
1.3.1 Nuclear periphery and genome organization 
Chromatin organization within the interphase nucleus is not random. 
Early electron microscopy revealed darker stained areas of dense chromatin 
within the interphase nucleus (Moses, 1956), that were termed 
heterochromatin. These areas tend to be proximal to the NE in most cell 
types although this dense chromatin is also present at nucleoli and 
centromeres. In contrast to the centromeric heterochromatin, the amount of 
which varies very little between different cell types, the amount of dense 
chromatin at the NE differs substantially from one cell type to another (Milner, 
1969). These observations implied a non-random organization of chromatin. 
In fact, the phenomenon of non-random organization of chromatin was 
already observed by Carl Rabl long before the electron microscopy era over 
a century ago. Studying salamander larvae he found that centromeres are 
located at one side of the nucleus, usually close to the centrosome (Figure 6, 
left), even though the centrosome localized outside the nucleus (Rabl, 1885). 
This special chromatin configuration was later coined after its discoverer. The 
Rabl configuration also ascribes the phenomenon where telomeres are 





Figure 6. The Rabl configuration. Centromeres are accumulating at the pole of 
the nucleus where the centrosome is proximal (left) or telomeres localize to one side 
of the nucleus (right). (Figure adapted from Zuleger and Schirmer, 2011)  
 
Also work from Theodor Boveri suggested that the genome is not 
randomly organized. He made the first observation that chromosomes 
occupy specific conformations within the interphase nucleus (Boveri, 1909) 
and thus proposed the concept of distinct chromosomal territories within the 
interphase nucleus. It was only 70 years later when a definitive study 
performed by Thomas and Christoph Cremer provided experimental 
evidence that chromosomes are not randomly organized within the 
interphase nucleus (Zorn et al., 1979). In this study DNA damage was 
induced with a microlaser in a small part of the cell nucleus under the 
experimental rationale that, if chromosomes are randomly organized and 
thus strongly intermingled with each other with no defined territories, then the 
laser will damage many or possibly all chromosomes (Figure 7, left). 
However, if organized in isolated non-overlapping territories, the laser will 
damage only a few chromosomes (Figure 7, right). The study found that only 
very few chromosomes were damaged by the laser, implying that indeed 
chromosomes are occupying compact regions within the interphase nucleus, 





Figure 7. Experimental testing of the two models for chromosome 
positioning in the interphase nucleus. A laser pulse is damaging a small 
region of the nucleus. If the chromosomes in the nucleus are randomly organized 
and strongly intermingled, many of them or even all will be damaged by the laser 
(left). If chromosomes are organized in distinct non-overlapping territories, the laser 
will damage only few chromosomes (right). (Image adapted from Meaburn and 
Misteli, 2007) 
 
However, the visualization of such chromosome territories could only 
be realized later when high resolution microscopy combined with 
fluorescence in situ hybridization (FISH) techniques were developed 






Figure 8. Chromosomes in interphase nuclei occupy specific territories. 
(A) Micrograph of a nucleus where all individual chromosomes are visualized. (B) 
False colour image of all chromosomes in a nucleus. (C) Modelling of the 
chromosome territories by a computer algorithm. (Panel A adapted from Hubner and 
Spector, 2010 and is originally from Andreas Bolzer and Irina Solovei; panel B and 
C adapted from Bolzer et al., 2005) 
 
But are these territories themselves randomly organized within the 
nucleus or do chromosomes occupy particular regions within the 3-
dimensional nuclear framework? This question was addressed by the 
Bickmore laboratory in a study which demonstrated that in human fibroblasts 
chromosome 18 tends to locate to the nuclear periphery while chromosome 
19 tends to be internal [Figure 9, A; (Croft et al., 1999)]. Intriguingly, since the 
peripheral chromosome 18 was gene-poor and the interior chromosome 19 
gene-rich it was proposed that gene-density might play a role in determining 
whether a chromosome is located in the nuclear interior or at the nuclear 
periphery. Later, the Misteli laboratory confirmed this non-random 
organization of the chromosome territories when they demonstrated that 
chromosomes that are most commonly involved in tissue-specific tumor 
translocations tend to be adjacent to one another in these particular tissues 
(Parada et al., 2002).  
Later, spatial positions of chromosome territories were shown to vary  
between different tissues (Parada et al., 2004; Stadler et al., 2004), showing 
that in mouse, for example, chromosome 5 is at the nuclear periphery in lung 





Figure 9. Non-random and tissue-specific positions of chromosome 
territories within the nucleus. (A) In human cells chromosome 18 (green) tends 
to reside at the nuclear periphery while chromosome 19 localizes in the nuclear 
interior. (B) In mouse chromosome 5 is in the interior in liver cells but peripheral in 
lung cells. (panel A is adapted from Croft et al., 1999; panel B is adapted from 
Parada et al., 2004) 
 
Moreover, it seems that tissue-specific chromosome patterning is 
established during differentiation since repositioning of chromosomes was 
observed in adipogenesis (Kuroda et al., 2004; Szczerbal et al., 2009), 
erythroid (Galiova et al., 2004) and T-cell differentiation (Kim et al., 2004). 
Furthermore, the idea that specific chromosome patterning is established 
during differentiation is also coherent with general assumption that chromatin 
is generally less specifically organized in undifferentiated cells. Interestingly, 
the observations that chromosome positions differ between cell-types and 
also change during differentiation questioned the previously established 
proposal that gene-density determines the chromosomes’ 3-dimensional 
position. Since gene-density of a chromosome is a factor that remains 
constant during differentiation, clearly other factors, likely being tissue-
specific themselves, must be involved in the tissue-specific spatial 






With the evidence of non-random chromosome positioning clearly 
established, the question arose:  
 
 
1.3.2 NE proteins can interact with chromatin 
components – Implication for NE-mediated 
chromosome organization 
Previous studies have shown that a small portion of an internal 
chromosome can stretch out to interact with the nuclear periphery (Kupper et 
al., 2007), indicating that NE components could contribute to particular 
organizational patterns of chromosomes within the interphase nucleus. It was 
not surprising since several NE proteins can bind chromatin and chromatin 
related components [Figure 10; reviewed in (Mattout-Drubezki and 
Gruenbaum, 2003)]. Lamins, for example, bind chromatin structures like 
telomeres and centromeres (Baricheva et al., 1996; Shoeman and Traub, 
1990) and interact with core histones H2A and H2B (Goldberg et al., 1999; 
Hoger et al., 1991; Taniura et al., 1995).  
NETs can also bind DNA directly. LAP2β binds DNA via its N-terminal 
domain (Cai et al., 2001) while another NET, MAN1, binds DNA by its C-
terminus (Caputo et al., 2006). The vast majority of NET interactions reported 
thus far have been with chromatin proteins or chromatin associated 
components. The lamin B receptor binds core histones H3 and H4 
(Polioudaki et al., 2001) and can bind heterochromatin via heterochromatin 
proteins HP1α and γ (Ye and Worman, 1996). LEM domain-containing 
proteins LAP2β (Furukawa, 1999), emerin (Lee et al., 2001) and MAN1 
(Mansharamani and Wilson, 2005) bind to chromatin via BAF (barrier-to-
autointegration factor), which itself is a chromatin binding protein.  





Figure 10. NE proteins interact with chromatin proteins. The INM of the NE 
possesses a specific set of NETs (orange), which together with the lamins are 
referred to as the lamina. Lamins, NPCs and NETs can all interact with DNA directly 
or via chromatin components like barrier-to-autointegration factor (BAF), 
heterochromatin protein 1 (HP1) and histones (red).      
 
Also NE protein interactions with epigenetic marks and enzymes 
involved in epigenetic modifications have been reported. For example, 
chromatin that co-immunoprecipitated with LBR was enriched in silent 
epigenetic marks (Makatsori et al., 2004). LBR also interacts with the 
methylcytosine binding protein MeCP2 (Guarda et al., 2009) while other 
NETs LAP2β and SUN1 bind to histone deacetylase HDAC3 (Somech et al., 
2005) and acetyl transferase hALP1 (Chi et al., 2007), respectively. Apart 
from chromatin binding enzymes that can modify chromatin NETs have also 
been shown to interact with several transcriptional regulators [reviewed in 
(Heessen and Fornerod, 2007)]. Emerin, for example, binds to Lmo7 
(Holaska et al., 2006), Btf (Haraguchi et al., 2004) and germ cell-less [GCL; 
(Holaska et al., 2003)] whilst MAN1 binds Smad proteins (Osada et al., 2003; 




Many novel NETs have been discovered recently (Dreger et al., 2001; 
Korfali et al., 2010; Nili et al., 2001; Schirmer et al., 2003; Wilkie et al., 2011), 
many of which are likely to bind chromatin proteins, chromatin modifying 
enzymes or DNA. Indeed a recent study, which ran visual screens on ten of 
these novel NETs, found that some of these proteins could reposition a gene 
locus to the nuclear periphery (Korfali et al., 2010).   
 
1.3.3 What are the mechanisms that direct cell-type 
specific chromosome organization patterns? 
Despite the assumption that the NE could be one of the major players 
in the establishment of tissue-specific chromosome positioning, direct testing 
of this hypothesis has proven difficult. First attempts involved the 
observations that a truncated form of lamin B1 caused a release of the 
peripheral chromosome 18 into the nuclear interior (Malhas et al., 2007). 
Similarly, disease-linked mutations of lamin A caused chromosome 13 and 
18 to move away from the nuclear periphery (Meaburn et al., 2007; Mewborn 
et al., 2010). Indeed, these lamin associated effects could also be indirect 
since targeting of many NETs is lamin-dependent [reviewed in (Schirmer and 
Foisner, 2007)]. Therefore it is reasonable to assume that NETs could be the 
actual mediators of chromosome positioning effects.  
The hypothesis that NE proteins could mediate specific chromosome 
positioning patterns emerges from the observation that the NETs emerin and 
LBR bind to distinct positions on chromosomes during mitosis (Haraguchi et 
al., 2000) and accordingly establish chromosome attachment points, which 
potentially could lead to the establishment of specific chromosome 
organization patterns once the NE is reformed. The above studies all 
describe widely expressed NE proteins and it is therefore also difficult to 
envision that they are the main drivers of tissue-specific chromosome 
positioning patterns. Moreover, the studies also provide only correlative 




chromosomes and do not provide direct evidence that NE proteins are 
tethering chromosomes to the nuclear periphery.  
The first evidence that a chromosome can be tethered to the NE was 
provided independently by three laboratories, which made use of an artificial 
high affinity system to tether chromosomes in a controlled fashion to the 
nuclear periphery (Finlan et al., 2008; Kumaran and Spector, 2008; Reddy et 
al., 2008). In all three studies, bacterial lac operator (lacO) sequences were 
integrated into the mammalian genome into a locus that tended to be in the 
nuclear interior. Additionally the lac repressor (lacI) was fused to either a 
GFP reporter alone or to both a reporter and a NE protein and expressed in 
these cell lines. While the expression of the lacI-reporter fusion (not bound at 
the NE) had no effect on chromosome positioning, the NE protein-fused lacI 
moved the lacO array, and also the according chromosome as tested in the 
Finlan et al. study (the other two studies did not test whether the lacO array 
containing chromosome was also moving), to the nuclear periphery (Figure 
11).  
Notably, though all three studies used different NE proteins they all 
found that tethering of the chromosome required a full mitotic cell division 
(Figure 11, B) suggesting that large-scale chromosome arrangements are 





Figure 11. Chromatin can be tethered to the nuclear periphery by an 
affinity mechanism. (A) A bacterial lacO array locus is integrated into the 
genome of a mammalian cell. This locus tends to be in the nuclear interior and is 
transcriptionally active. (B) The lac repressor (lacI), a bacterial protein with a high 
affinity to the lacO array is fused to a NE protein and introduced into the cell. When 
the cell goes through mitosis, the NE brakes down into small vesicles, some of 
which contain the lacI-NE fusion protein. These vesicles bind to the lacO array. (C) 
When the NE is reformed after mitosis lacI-fusion is captured at the nuclear 
periphery together with the lacO array. The array containing locus becomes 
transcriptionally inactive at the NE. (Figure adapted from Zuleger and Schirmer, 
2011) 
The findings of the three studies advanced our understanding of 
chromosome organization enormously as they all provided first proof that a 
chromosome can be recruited to the nuclear periphery via a NE tether. But 
even though the proof of principle is provided, endogenous proteins that 
could tether chromosomes to the nuclear periphery have yet to be found. The 
three lacO studies also tested for transcriptional changes of the 
locus/chromosome upon its tethering to nuclear periphery and the findings 





1.3.4 Gene regulation as a consequence of radial 
chromosome repositioning 
It is reasonable to assume that repositioning of a particular 
chromosome will have transcriptional consequences on the genes located on 
this chromosome. For instance, if a chromosome would move from the 
interior to the nuclear periphery, which as mentioned earlier is a 
predominantly silent environment, the genes of this chromosome adjacent to 
the NE should be silenced. In fact, in the previously mentioned lacO studies 
the activities of genes proximal to the lacO array were tested. And indeed in 
two of the studies a preference for gene silencing was observed (Finlan et 
al., 2008; Reddy et al., 2008). In the third study the transcriptional activity of 
the tethered locus was not affected (Kumaran and Spector, 2008). These 
discrepancies might reflect the usage of different tether proteins which in turn 
recruit different transcriptional regulators, or are due to differences in the cell 
lines. Another possible explanation for the difference is also the use of the 
very strong promoter (early SV40 promoter) in the Kumaran and Spector 
study, the activity of which could likely override any positioning effects.   
Additionally, inconsistencies have been observed in systems where no 
artificial tethering systems were used. For instance, some genes were 
reported to move from the periphery into the interior when activated; others 
however, remained at the periphery after activation.  For example, the C-maf 
(Hewitt et al., 2004), IgH (Kosak et al., 2002), β-globin (Ragoczy et al., 2006) 
and Mash1 [Figure 12, A; (Williams et al., 2006)] genes are all repressed at 
the nuclear periphery but become activated and move into the nuclear 
interior when the cells are differentiating into T-cells, B-cells, erythroid cells or 
neural cells, respectively. Other genes like the PLP [Figure 12, B; (Nielsen et 
al., 2002)], IFN-γ (Hewitt et al., 2004), ERBB-2 (Park and De Boni, 1998) and 
the COL1A1 (Johnson et al., 2000), however remain at the nuclear periphery 






Figure 12. Radial positioning of genes and their transcriptional activity 
during differentiation. (A) The Mash1 gene (green spots) is inactive and 
localizes at the nuclear periphery in neural progenitor cells (left). During neuron 
differentiation the Mash1 gene becomes transcriptionally active and moves into the 
nuclear interior (right). (B) In contrast, the PLP gene (green spot) is at the nuclear 
periphery in progenitor cells (left) and in differentiated nerve cells (right) even though 
it becomes activated during neurogenesis. (panel A adapted from Williams et al., 
2006; panel B adapted from Nielsen et al., 2002) 
 
1.3.5 Differentiation, chromosome/gene repositioning 
and gene activity – The bigger picture 
Though the studies mentioned above observed a radial change in 
chromosome and gene positioning during differentiation, they were only 
testing for few genes and chromosomes and there was a clear need for a 
more systematic study that would address the interplay of chromosome 
organization and the functional readout of it. There are three recent reports 
all of which show the large scale chromatin re-organizations during 
differentiation in the light of a functional output. The first study studied the 
change in the nuclear architecture during the differentiation of rod 
photoreceptor cells of nocturnal and diurnal mammals and revealed that the 
nuclear architecture of these cells is adapting to vision (Solovei et al., 2009). 
The study found that whereas the nuclear architecture of rod photoreceptor 
cells of diurnal mammals matched that found in most eukaryotic cells with 




euchromatin in the nuclear interior. However, whilst the same organization 
was found in progenitor photoreceptor cells of nocturnal mammals, in 
differentiated rod photoreceptor cells of nocturnal mammals a completely 
inverted chromatin organization was observed in which heterochromatin 
localized in the nuclear interior surrounded by the euchromatin which lined to 
the nuclear periphery (Figure 13, A). It was proposed that the functional 
consequence of the inverted organization of rod nuclei was to allow them to 
act as collecting lenses and thus enhance the night vision of nocturnal 
mammals. 
The second study used the whole organism Caenorhabditis elegans to 
study the radial position of developmentally controlled tissue-specific 
promoters during differentiation (Meister et al., 2010). This study revealed 
that these promoters were not specifically organized in embryos but shifted 
robustly to the nuclear interior upon activation only in tissues the promoters 







Figure 13. Large-scale chromatin rearrangements during differentiation. 
(A) Arrangement of euchromatin (green), L1-rich heterochromatin (red) and 
heterochromatin of chromocenters (blue) in undifferentiated (top) and differentiated 
(bottom) rod photoreceptor nuclei. Most heterochromatin is peripheral and most of 
the euchromatin interior in undifferentiated cells while after the differentiation the 
arrangement is completely inverted. (B) Position of a muscle-specific promoter 
(myo-3) in throat differentiation (top) and muscle differentiation (bottom). The muscle 
promoter has no preferred position during throat differentiation but shifts robustly 
into the nuclear interior in muscle-differentiating cells. (panel A adapted from Solovei 
et al., 2009; panel B adapted from Meister et al., 2010) 
 
The last study investigated the dynamics of gene positioning with 
respect to the nuclear periphery during neurogenesis  (Peric-Hupkes et al., 
2010). This study mapped all genes in contact with the nuclear periphery in 
embryonic stem cells, lineage-committed neural precursor cells and 
completely differentiated astrocytes and found that many genes changed 
their positioning in respect to the nuclear periphery during the differentiation 
process. More importantly, genes becoming activated during the 
differentiation process often moved into the nuclear interior whilst being at 




evidence on a large-scale level for functional consequences of radial gene 
repositioning during differentiation.  
 
 
Many labs have studied chromatin movements in living insect and 
mammalian cells and reported gene movements of up to 10 µm in interphase 
cells (Chuang et al., 2006; Gunawardena and Rykowski, 2000; Solovei et al., 
2004) but for bigger chromosome domains and whole chromosomes reported 
movements did normally not exceed the 2 µm mark (Abney et al., 1997; 
Bornfleth et al., 1999; Edelmann et al., 2001; Marshall and Wilson, 1997; 
Thomson et al., 2004; Walter et al., 2003). It is therefore difficult to imagine 
that the huge chromosome re-organization patterns observed during 
differentiation could possibly occur during interphase, a rather more plausible 
explanation would be a establishment of a different chromosome 
organization during mitosis as also reported by the three lacO studies, where 
artificial high affinity tethering of an internal chromosome to the periphery 
required a mitotic cycle (Finlan et al., 2008; Kumaran and Spector, 2008; 
Reddy et al., 2008). Despite growing evidence that mitosis could be the 
prerequisite for large-scale chromosome reorganization, a recent study 
demonstrated that chromosomes can move large distances in post-mitotic 
cells in a step that required activity of cellular motors (Mehta et al., 2010).   
To directly test if mitosis is preceding large-scale chromosome 
rearrangements several studies followed the interphase chromosome 
organization of mother cells and the respective daughter cells. Though the 
individual studies all agree that chromosome territories are maintained during 
interphase, their results regarding chromosome organization after the cell 
went through mitosis differ. Some report an organization that is inherited to 
the daughter cells (Essers et al., 2005; Gerlich et al., 2003) while others 
report that the radial positioning of chromosome territories in interphase 
differes significantly from mother to daughter cells (Cvackova et al., 2009; 





Strickfaden et al., 2010; Thomson et al., 2004; Walter et al., 2003). Looking 
at the latter studies more closely one can recognize that even though huge 
re-arrangements seem to occur, minor radial positioning is preserved to 
daughter cells. For example, if mother cells had some chromosome portions 
at the nuclear periphery, then also daughter cells had at least some of the 
portions still a the nuclear edge (i.e. Figure 4A in Strickfaden et al., 2010). 
This would mean that some chromosomes are still at the periphery though 





We will only be able to work out the molecular mechanisms of 
chromosome repositioning once all the proteins responsible are discovered. 
Despite of growing evidence that the NE could be involved in chromosome 
repositioning, no study thus far has systematically manipulated the protein 
composition of the NE and then tested for possible effects on chromosome 
positioning. The number of NE proteins has increased from just a dozen to 
more than 100 within the last 10 years (Dreger et al., 2001; Korfali et al., 
2010; Schirmer et al., 2003; Wilkie et al., 2011). Given this enormous number 
it is reasonable to deduce that at least some could play a role in chromosome 
organization. Many of these novel NE proteins were isolated from specific 
tissues and thus could be tissue-specific. The more interesting it is to test, if 
some of them play a role in global chromosome organization since large-
scale chromosome re-arrangements occur also during differentiation (when 
many of the tissue-specific NETs are expressed). 
 Another important question is whether tethering of genes from one 
chromosome to the nuclear periphery causes the chromosome to change its 
What are the proteins that mediate chromosome positioning? 
AND 






radial position respectively or whether the chromosome repositioning itself is 
the cause for gene repositioning. Furthermore, it is not completely clear 
whether change in transcriptional activity is cause or consequence for radial 
repositioning of genes and chromosomes i.e. are genes that are silent at the 
nuclear periphery released into the nuclear interior in order to get activated or 
are they activated at the periphery first and move to the nuclear interior as a 
consequence of it? For example, strong transcriptional activation could 
change epigenetic marks to lower affinity for the periphery so transcription 
could drive the gene away from the periphery.  Alternatively, release from the 
periphery could move the gene into a transcriptionally active environment, for 
example in proximity to PML bodies, which would promote the activation of 
this gene. 
 An increasing amount of reports argues for the latter scenario where 
repositioning of the gene preceded its activation (Andrulis et al., 1998; 
Chambeyron and Bickmore, 2004; Chambeyron et al., 2005; Yao et al., 
2011). This scenario is also supported by the discovery of so called 
“transcription factories” or “expression hubs” (Jackson et al., 1993). These 
transcription factories are nuclear foci of many active genes with high 
concentrations of polymerases and transcription factors and the fact that 
many active genes must be concentrated in such a factory follows from the 
observation that the number of active genes in the cell is by far exceeding the 
number of these transcription factories. Hence, a repressed gene is more 
likely to move first in order to reach such a transcription factory in order to be 
subsequently activated. 
Answering all of the questions mentioned above will only be possible 
once the players responsible for the chromosome and gene re-arrangements 
are identified. Only then one can manipulate these players and test the 
effects on chromosome organization. We propose that many of these 
chromosome organizing proteins reside in the NE. The NE contains more 
than 100 NETs some of which have already been shown to alter chromatin 




specific tissues and therefore it is reasonable to deduct that they might play a 
potential role in tissue-specific chromosome organization.  
 
1.4 Preview 
This chapter focused on the important questions in the field of NE 
membrane protein targeting and nuclear periphery mediated genome 
organization. The answers to some of these questions are presented in the 
following chapters. For example, we are able to show that translocation of 
NETs is mediated by distinct mechanisms, which are independent from each 
other. Our further findings in this area also argue for the use of the peripheral 
rather than the central channels of the NPC for translocation of NETs into the 
INM.  
The following chapters will also give a possible explanation for how 
tissue-specific chromosome organization is established. We found tissue-
specific NETs, which could reposition chromosomes to the nuclear periphery 
upon their overexpression and release chromosomes from the periphery 
upon their depletion. Intriguingly, the expression of these chromosome 
repositioning NETs caused a differential expression of genes specific to the 










Chapter 2  
 
Materials and Methods 
 
2.1 Materials 
All standard reagents and chemicals if not otherwise stated were obtained 
from Sigma, Merck or Fisher Scientific. TRIzol reagent was obtained from 
Invitrogen. Formaldehyde was from Electron Microscopy Sciences. 
Bacterial strains 
DH5alpha 





StrataClone SoloPack Competent Cells (Stratagene, from kit 240207) 
F-  creC510 Φ80dlacZΔM15 recA1 endA1 tonA rpsL20 (StrR ) hsdR17(rK
-
mK
+)  λ– 
 
Buffers and solutions 
Denaturation buffer (FISH)  70% v/v Formamide in 2xSSC, pH7.2 
Hybridization buffer (FISH)  provided with STARFISH probes 
LB 1% tryptone; 0.5% yeast extract; 10mM 
NaCl; pH7.4 
PBS 65mM Na2PO4; 8.8mM KH2PO4; 137mM 




SSC, 20x    3M NaCl; 300mM Sodium Citrate; pH7.2 
TAE     40mM Tris-acetate; 1mM EDTA 
TfbI buffer 30mM KAc; 100mM RbCl2; 10mM CaCl2; 
50mM MnCl2; 15% glycerol; pH 5.8 
TfbII buffer 10mM MOPS; 75mM CaCl2; 10mM RbCl2; 
15% glycerol; pH 6.5 
SDS-page buffer   25 mM Tris; 192 mM glycine; 0.1% SDS;
    pH 8.3 
Transfer-Buffer   80% SDS-page buffer; 20% methanol  
Crosslinking solution 10x 500 mM Hepes pH 7.9; 1.5 mM NaCl; 10 
mM EDTA; 5 mM EGTA 
Buffer L1 (ChIP) 50 mM Hepes pH 7.9; 140 mM NaCl; 1 mM 
EDTA; 10% glycerol; 0.5% NP-40; 0.25% 
Triton X-100 
Buffer L2 (ChIP) 10 mM Tris pH 8.0; 200 mM NaCl; 1 mM 
EDTA; 0.5 mM EGTA 
Buffer L3 (ChIP) 10 mM Tris pH 8.0; 1 mM EDTA; 0.5 mM 
EGTA 
ChIP dilution buffer 20 mM Tris pH 8.0; 150 mM NaCl; 2 mM 
EDTA; 1% Triton X-100 
Wash buffer 1 (ChIP) 20 mM Tris pH 8.0; 150 mM NaCl; 2 mM 
EDTA; 1% Triton X-100; 0.1 % SDS  
Wash buffer 2 (ChIP) 20 mM Tris pH 8.0; 500 mM NaCl; 2 mM 
EDTA; 1% Triton X-100; 0.1 % SDS 















acetyl histone H3/rabbit WB/1:500 Millipore (06-911) 
-actin/mouse WB/1:5000 Sigma (A1978-200UL) 
Digoxigenin/mouse FISH/1:300 Roche (11333062910) 




GFP/rabbit IP/1:100 Rabbit polyclonal generated 
against the whole protein (antigen 
purified by Dzmitry Batrakou) 
NET5/rabbit WB/1:250 Millipore (06-1013) 
NET29/rabbit WB/1:250 Millipore (06-1018) 
NET39/rabbit WB/1:250 Millipore (06-1025) 
NET45/mouse WB/1:500 Monoclonal made to a protein 
fragment by Dr. Glenn E. Morris 
and Natalie Randals 
NET47/rabbit WB/1:250 Millipore (06-1026) 
NET55/rabbit WB/1:250 Millipore (06-1029) 
Nup35/mouse WB/1:1000 Tebu-Bio (157H00129401-B01) 
Porin/rabbit WB/1:500 Abcam (ab15895) 
Ran/mouse WB/1:5000 BD Biosciences (610341) 
tri-methyl hist. H3/rabbit WB/1:500 Millipore (07-523) 







Secondary antibodies for IF/FISH were anti rabbit or anti mouse Alexa dye 
conjugates (Molecular Probes, Invitrogen). For Western blotting horseradish 
peroxidase conjugated highly cross-absorbed anti rabbit or anti mouse 
antibodies were applied. All secondary antibodies used are listed in the table 
below.   









Anti-mouse Alexa 568 IF/FISH/1:200 Invitrogen (A11031) 
Anti-rabbit Alexa 594 IF/FISH/1:200 Invitrogen (A21207) 
Anti-mouse HRP WB/1:3000 Promega (W4021) 
Anti-rabbit HRP WB/1:5000 GE Healthcare (NA9340-1ML) 
  
Avidin conjugates 
Avidin (A21370) or Strepavidin (S32356) were used conjugated to Alexa 












StarFISH whole chromosome paints were obtained from Cambio 
(Cambridge, UK) and are listed in the table below. 
Table 3. Whole chromosome paints used in this study  
Chromosome paint Cat. Nr. 
concentrated Human Chromosome 1 paint 1066-1B-02 
concentrated Human Chromosome 5 paint 1066-5B-02 
concentrated Human Chromosome 11 paint 1066-11B-02 
concentrated Human Chromosome 13 paint 1066-13B-02 
concentrated Human Chromosome 17 paint 1066-17B-02 
concentrated Human Chromosome 19 paint 1066-19B-02 
 
Cells 
HeLa, HT1080 and HepG2 cells were obtained from ATCC. HT1080 cells 
stably expressing GFP-NETs were established during the course of this 
study. 293T cells stably expressing BAF-GFP were obtained from Dr. Nadia 
Korfali, Wellcome Trust Centre for Cell Biology, Edinburgh, UK. HT1080 cells 
with stably integrated lac operator (lacO) repeats and stably expressing the 
lac repressor-GFP (lacI) were a gift from Professor Wendy Bickmore (MRC 
Human Genetics Unit, Edinburgh). In short, the 128mer lacO array plasmid 
was linearized and co-transfected with a selection plasmid into HT1080 cells. 
Cells were selected with 5 g/ml blasticidin S. For visualization of the lacO 
array integration these cells were further transfected with a linearized vector 
containing lacI-GFP. Cells were selected for this plasmid with 100 g/ml 







Table 4. Commercial Kits used in this study 
Kit Provider 
QIAprep Spin Miniprep Kit (27106) Qiagen 
QIAfilter Plasmid Midi Kit (12243) Qiagen 
QIAquick Gel Extraction Kit (28704) Qiagen 
StrataClone Blunt PCR Cloning Kit (240207) Stratagene 
Illumina® TotalPrep™ RNA Amplification Kit (AMIL1791) Ambion 
Fugene HD transfection reagent (04709691001) Roche 
Nucleofection Kit R (VCA-1001) Lonza 
Nucleofection Kit V (VCA-1003) Lonza 
RNAi oligos 
ON-TARGETplus Smartpool siRNA oligos against transcripts of human 
NET45 (DAK; L-006808-00-0020) and human NET47 (TM7SF2; L-005744-
00-0020) were obtained from Dharmacon. For Nup35 siRNA-mediated 
knockdown following RNA oligos were used as a duplex: 5’-
UGCCCAGUUCUUACCUGGATT-3’ (sense) and 5’-
UCCAGGUAAGAACUGGGCATT-3’ (antisense). The bold marked “TT” 
symbolizes DNA overhangs. For live-cell imaging detection of Nup35 siRNA 
transfected cells the antisense oligo was conjugated to the Alexa-647 dye at 
the 5’-end. 
Human tissue blots and human biopsy tissues 
A ready-to-use polyvinylidene fluoride (PVDF) membrane containing lysates 
from eleven human tissues was obtained from IMGENEX (IMB-103). Human 
biopsy liver and kidney tissue sections were provided by Professor David J. 
Harrison (Western General Hospital, Edinburgh, UK) in line with University of 





2.2.1 Nucleic acid methods 
Standard Cloning techniques involving transformation of plasmid DNA into 
bacteria, amplification of plasmid DNA in bacteria and plasmid isolation, 
restriction of DNA plasmids, agarose gel elecrtrophoresis were performed as 
described by Sambrook and Russell (2001) and applied to obtain the 
expression plasmids used in this study. Plasmids not designed in this study 
are clearly indicated. The quality and concentration of the isolated plasmid 
DNA or RNA was assessed using the spectrophotometer NanoDrop 2000c 
(Thermo Scientific). 
 
2.2.1.1 Polymerase chain reaction 
Phusion High-Fidelity DNA Polymerase (Finnzymes) was used to amplify the 
genes of interest using the appropriate primers. The primers used are listed 
in the table below: 
Table 5. Primers used in this study  
Primer Sequence (5’-3’) Restriction 
site 
NET5_1stSol_fw AAGCTTTACGGAGGATGAAGCCAACG HindIII 
NET5_1stSol_rv GTCGACCTTCACGGCGGAGGAGAAG SalI 
NET5_2ndSol_fw AAGCTTTAAGGAAGGCAACGGGC HindIII 
NET5_2ndSol_rv GTCGACACGACCTCTCCAGGTG SalI 
NET39_Sol_fw AAGCTTTAATGCCAGCTTCCCAGAG HindIII 
NET39_Sol_rv GTCGACGGAGCGGGCACTGG SalI 
NET47_Sol_fw AAGCTTTAAAGGCGCAGGTAGCC HindIII 
NET47_Sol_rv GTCGACCCCGTCATGTGTGATATCCATG SalI 
Sol = soluble fragment; fw = forward primer; rv = reverse primer 
 
The total reaction volume of 20μl contained 0.4U Phusion Polymerase 




DNA, 4 μL of the 5x Phusion buffer (provided with the enzyme) and double 
distilled water. PCR reactions were run on the G-STORM GS1 cycler.  
The PCR reaction had following cycling parameters:  
1) 2 min at 95°C (denaturation) 
2) 20 sec at 95°C (denaturation) 
3) 30 sec at 58°C (primer annealing) 
4) 72°C for 1min/1kb target sequence (extension) 
Step 2 to 5 was repeated 25-30 times followed by a 5 min extension step at 
72°C.  
 
Final PCR products were analysed by means of agarose gel electrophoresis 
and cloned into the intermediate vector using the StrataClone Blunt PCR 
Cloning Kit (240207) from Stratagene following the manufacturer’s 
instructions. 
 
2.2.1.2 Sequencing of plasmid DNA 
The entire sequence of the cDNAs cloned into the expression vectors was 
verified by sequencing. Sequencing was performed by the GenePool 
sequencing facility (University of Edinburgh). Provided chromatograms were 
analyzed using the freeware program FinchTV (Geospiza).  
 
2.2.1.3 Isolation of total cellular RNA 
Cells from a sub-confluent 10 cm culture dish were trypsinized with 2 ml 
trypsin/PBS solution and the trypsinization was stopped by adding 4 ml of 
fresh complete medium containing 10% serum to inactivate the trypsin. Cells 
were then pelleted and harshly resuspended in 1ml TRI-reagent (Invitrogen) 
and incubated at RT for 5 min. 200 µl chloroform was added and the mixture 
vigorously shaken for 20 sec and then let to incubate at room temperature for 
10 min. The mixture was then spun at 12,000xg for 12 min at 4ºC. After 
centrifugation the supernatant was removed and put into 500 µl isopropanol, 




10 min at 12,000 xg and 4ºC was performed to pellet the RNA. The 
supernatant was discarded and the pellet washed in 70% ethanol. After a 2 
min spin at 6,000xg at 15ºC the supernatant was removed and the pellet was 
resuspended in 50 µl molecular grade RNase-free water and used for RT-
PCR or biotin labelling for microarrays. RNA that was not subsequently 
processed was stored at -80 ºC. 
 
2.2.1.4 Reverse transcriptase PCR 
For the reverse transcriptase PCR reaction the Titan kit (Roche, 
11855476001) was used. For the reaction following components and their 
according amounts were pipetted: 
total RNA (50ng/ µl)    2 µl 
primer1/primer2 mix (2.5µM each) 4 µl 
dNTPs (25mM)    0.2 µl 
RT-PCR buffer    2 µl 
MgCl2      0.6 µl 
DTT      0.5 µl 
Reverse transcriptase   0.2 µl 
H2O      0.5 µl 
RT-PCR Program: 
1) 45 min  48°C 
2) 2 min  95°C 
3) 20 sec  95°C 
4) 25 sec  56°C 
5) 1 min  68°C 





2.2.1.5 Biotin labelling of total RNA and microarray analysis 
Total RNA preparations were transcribed into cDNA and then subsequently 
into biotin labelled cRNA using the Illumina® TotalPrep™ RNA Amplification 
Kit (Applied Biosystems, AMIL1791) following the manufacturer’s instructions 
(This work was performed by Dzmitry Batrakou). Labelled cRNA was 
hybridized to Illumina HumanHT-12 v3 bead arrays containing 48803 probes 
covering UniGene and RefSeq annotated genes (performed by the Wellcome 
Trust Clinical Research Facility, Western General Hospital, Edinburgh, UK). 
The subsequent microarray data were normalized using the free statistics 
package R (R Development Core Team (2011); R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, 
Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/). A low 
intensity filter was applied to eliminate samples that do not reach the 
log2(signal) of at least 6.5. Afterwards, all transcripts that exhibited small 
expression differences were eliminated using a cut-off of 1.4 (abs(log2 
NET/ref)=0.5) (this was done by Dr. Jose de las Heras). 
 
2.2.2 Protein techniques  
2.2.2.1 Western blotting 
Cell lysates or purified proteins were separated on 8-12% SDS-Gels. 
Subsequently the gels were transferred onto a ImmobilonP membrane 
(Millipore) by means of semidry transfer (BIO-RAD). After transfer the 
membrane was blocked in 5% milk powder (in PBS with 0.05% Tween-20) 
for 60 min. Subsequently, the membrane was incubated with the primary 
antibody (1:500 in PBS/Tween20/5% milk) for 45 min. Six washes in 
PBS/Tween20/5% milk were followed by incubation with the secondary 
antibody conjugated to the horse-radish peroxidase (HRP, 1:10000 in 
PBS/Tween20/5% milk) for 30 min. After 6 washes in PBS/Tween20 the 




HRP to react with hydrogen peroxide and luminol to generate a fluorescent 
signal that was measured on an X-Ray film (CP-BU NEW, Agfa).  
 
2.2.2.2 Chromatin IP (ChIP) procedure1  
Cells stably expressing GFP fusion proteins were grown to 90% confluence, 
trypsinized and counted. 107 cells were aliquoted and crosslinked in a total 
volume of 10 ml at 4°C for 10 min with 1x crosslinking buffer containing 1% 
formaldehyde. Crosslinking was stopped by adding glycine at a final 
concentration of 125 mM. Subsequently, cells were collected by 
centrifugation at 400xg for 6 min and washed twice with PBS containing 
freshly added protease inhibitors (Roche 11873580001). Pellets were 
resuspended in 5 ml of protease inhibitors-containing Buffer L1 and 
incubated at 4°C for 10 min with gentle rocking. Cells were again collected by 
centrifugation at 800xg for 10 min and subsequently resuspended at a 
concentration of 2 x106 cells/ml in Buffer L2 (containing protease inhibitors) 
for an incubation at 4°C for 10 min. After collecting again by centrifugation, 
pellets were resuspended in 500 µl of Buffer L3 and SDS was added to a 
final concentration of 0.01%. The mixture was then sonicated using a 
BioRuptor bath sonicator on high power for 20 pulses of 30 s each followed 
by a 30 s rest (so 10 min of actual sonication), adding fresh ice every 5 min. 
Roughly 1/10 volume of the sonicated lysate was removed and boiled in SDS 
sample buffer and used as input material on Western blots. Lysates were 
pre-cleared with a mixture of protein A (Millipore, LSKMAGA02) and protein 
G (Millipore, LSKMAGG02) magnetic beads for 1 h at 4°C. After removal of 
the beads samples were incubated with rabbit GFP antibodies (made to the 
whole protein) overnight at 4°C on a rotating wheel. On the next day 50 µl of 
a mix of protein A and G magnetic beads (Millipore) was added followed by 
incubation for 3 h at 4°C on a rotating wheel. Beads were washed 5 times in 
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 the ChIP protocol was kindly provided by Dr. Irina Stancheva (Wellcome Trust Centre for Cell Biology, 
Edinburgh, UK); The ChIP procedure was performed by Dr. Nadia Korfali (Wellcome Trust Centre for 




500 µl Wash buffer 1 followed by 3 washes in 500 µl of Wash buffer 2. To 
remove the bound proteins from the beads SDS sample buffer was added 
followed by boiling. The eluted material was then analyzed by SDS-PAGE 
and western blotting. 
 
2.2.3 Tissue culture methods 
2.2.3.1 Mammalian cell maintenance and transfection 
HeLa, HepG2 and HT1080 cells were grown in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal calf serum, 100 units/ml 
penicillin, and 100 μg/ml streptomycin. HT1080 cells were additionally 
supplemented with 100μg/ml hygromycine and 5μg/ml blasticidin S to keep 
them selected for the stably integrated lacO amplifications and the lacI-GFP 
coding sequence. Cells were plated onto 10 mm coverslips (VWR 
International) in 24-well plates. Once they had achieved 20% confluency, 
they were transfected with 0.5 µg reporter using Fugene HD (Roche). 
2.2.3.2 Establishment of stable cell lines 
To establish stable cell lines plasmids carrying the gene of interest and the 
geneticin resistance cassette were linearized and transfected into HT1080 
cells using Fugene HD (Roche) following the manufacturer’s instructions. At 
two days post-transfection Geneticin (Invitrogen) was added at 500 µg/ml 
and maintained for two weeks to select for stable transfectants. These cells 
were subsequently sorted by FACS to select for cells with similar expression 
levels. After sorting cells were maintained in 100 µg/ml Geneticin. 
2.2.3.3 ATP depletion in HeLa cells 
HeLa cells were depleted for ATP by exchanging regular culture medium for 
glucose-free medium containing 10mM sodium azide and 6 mM 2-




initiated 10 min after the medium exchange. Cells were discarded 40 min 
after the medium exchange to avoid pleiotropic effects from ATP depletion. 
2.2.3.4 Ran function depletion in HeLa cells 
To inhibit Ran function during FRAP experiments a plasmid encoding the 
dominant negative mutant of Ran was co-transfected with GFP-NETs. This 
mutant has a glutamine to leucine substitution at amino acid position 69 
(Q69L). Because Ran function is impaired by Ran fusion to ectopic tags the 
plasmid also contained monomeric RFP, expression of which was driven by a 
separate CMV promoter enabling visualization of Ran mutant expressing 
cells. For Ran depletion this construct was co-transfected with NET-GFP 
constructs and cells were analysed 24h post-transfection. A Ran antibody 
was used to detect increased Ran levels in the total population by western 
blotting and in individually transfected cells (as determined by expression of 
monomeric RFP) by immunofluorescence.  
 
2.2.3.5 Nup35 depletion in HeLa cells 
The nucleoporin Nup35 was depleted from HeLa cells by means of siRNA. 
RNAi duplexes designed to target the 5’-UGCCCAGUUCUUACCUGGA-3’ 
region of the human Nup35 mRNA. Cells were used for experiments 48-60h 
post nucleofection of 7µg siRNA oligos into one million cells using 
nucleofection kit R and program I-013. The siRNA duplexes were conjugated 
to Alexa647 dye in order to visualize transfected cells. The extent of Nup35 
knockdown was assessed by western blotting using an anti-human Nup35 
polyclonal antibody. 
2.2.3.6 Knockdown of NET45 and NET47 in HepG2 liver cells 
Smartpools were obtained from Dharmacon for NET45 (DAK; L-006808-00-
0020) and NET47 (TM7SF2; L-005744-00-0020). 3 µg of each oligo mix was 
combined and transfected into 1.5 x 106 HepG2 cells using nucleofection 




sequence (sense strand: 5’-CGUACGCGGAAUACUUCGA-3’; antisense strand 
5’-UCGAAGUAUUCCGCGUACG-3’). Cells were taken for RNA at 48 h or fixed 
at the indicated time points post-transfection. Peptidylprolyl Isomerase A 
(PPIA) was used as a loading control. 
 
2.2.4 Microscopy methods, image processing and analysis 
2.2.4.1 Fluorescence recovery after photobleaching (FRAP) 
FRAP experiments were performed on a wide-field microscope (DeltaVision, 
Applied Precision; IX70 microscope, Olympus and CoolSNAP HQ camera, 
Photometrics) with an attached 488 nm laser using a 60x Plan-Apochromat 
oil 1.4 NA objective lens. HeLa cells were analyzed 16-24 h post transfection 
with NET-GFP fusions in a 37°C heated chamber containing complete culture 
medium with 25mM Hepes-KOH. Five pre-bleach images were taken before 
cells were bleached with a ~5.5 µm2 laser spot at full laser intensity leaving 
subsequent fluorescence levels of 20-40%. Fluorescence recovery was then 
measured every 3.5s until a recovery plateau was reached. Image data were 
collected with SoftWoRx software (version 3.5) and processed with Image-
Pro Plus Analyzer 6 (Media Cybernetics). A Visual Basic based “in house” 
algorithm (written by Dr. David Kelly, Wellcome Trust Centre for Cell Biology, 
Edinburgh, UK) was applied to Image Pro Plus in order to normalize the 
fluorescence recovery and to calculate the t1/2s as previously described 
(Phair and Misteli, 2001). Briefly, one region of interest was measured in the 
background, the whole cell and the bleached area. Those three regions were 
measured for each time frame to be able to correct for photobleaching 
compared to the five prebleach images taken. If the imaged cell moved the 
measured region of the bleached area was adapted manually in xy position 
for each frame. Recovery halftimes were calculated from normalized 
fluorescence values, while the immediate post-bleach value was set to 0% 





2.2.4.2 GFP-photoactivation (GFP-PA) 
GFP-PA experiments were performed on the confocal microscope SP5 
(Leica) using a 60× 1.4 NA objective lens and a 405 nm UV laser. HeLa cells 
were co-transfected with PA-GFP-NET fusion and monomeric RFP tagged 
NET20 in order to visualize the NE and the ER (observations from our lab 
indicate that NET20 is not likely to interact with NE components). During PA 
experiments cells were maintained in a 37°C heated chamber containing 
complete culture medium and gassed with a mix of 5%CO2 and 95% air. The 
region to be activated was chosen according to the NET20-mRFP signal 
(about one third of the NE was activated for NE measurements and for ER 
measurements all of the ER, which was at least 2 microns away from NE was 
activated to avoid cross-activation of the NE). Activation was performed with 
8% laser power (UV laser, 405 nm) for 0.5s and distribution of the activated 
GFP fluorescence was measured at 1% laser  power (Argon laser 488 nm 
line) every 10s. Image data were collected with the SP5 application suite 
(Leica) and processed with Image-Pro Plus 7 software (Media Cybernetics). 
Briefly, after activation of either the NE or the ER area the fluorescence total 
intensity of the non-activated NE portion was measured for each frame. The 
initial value of the non-activated NE part was set to 100 and the intensities of 
the subsequent frames adjusted accordingly. Normalized intensities for each 
frame were averaged from different experiments and plotted. 
  
2.2.4.3 Indirect immunofluorescence techniques and imaging analysis 
Three days post-transfection cells were washed once with PBS and fixed in 
4% formaldehyde (in PBS) for 7 min. Subsequently cells were washed three 
times with PBS and then incubated 5 min with 0.1% Triton-X100 (in PBS) to 
permeabilize the cell membrane for antibody access. After 3 washes with 
PBS cells were blocked with 5% BSA in PBS for 20 min followed by a 45 min 
incubation with the primary antibody (in PBS/5%BSA) against the 
corresponding antigen. Three washes with PBS were followed by a 30 min 




incubation cells were washed with PBS and mounted with Fluoromount-G 
(EM Sciences) onto glass slides and used for microscopy. 
2.2.4.4 Fluorescence In Situ Hybridization (FISH) 
For fluorescence in situ hybridization (FISH) all cells were fixed in 4% 
paraformaldehyde/PBS and then aged for 2 days in the fridge. After aging 
cells were pre-permeabilized in 0.2% Triton-X-100/PBS for 5 min, washed 3 
times in PBS and then blocked with blocking buffer (2% BSA/0.1% 
Tween20/PBS) for 20 min at room temperature. Primary antibody incubations 
were then performed at 37°C for 1 h and secondary antibody incubations for 
45 min in blocking buffer. After 3 washes in PBS cells were again fixed with 
2% formaldehyde for 5 min to fix antibodies prior to denaturing FISH steps. 
After antibody fixations cells were permeabilized with 0.5% Triton X-100/PBS 
for 5 min and subsequently washed 3 times with PBS.  
Further, cells were pre-equilibrated in 2x SSC and treated with RNase 
(100 µg/ml) at 37°C for 1 h. After washing in 2x SSC cells were dehydrated 
with a 70%, 90% and 100% ethanol series. Slides were backed at 70°C in an 
oven for 5 min and then submerged in pre-heated (80°C) 70% formamide/2x 
SSC (pH 7.2) for 20 min followed by a incubation in ice cold 70% ethanol for 
2 min and another ethanol dehydration series. Slides were air dried and pre-
heated to 37°C on a heating block. For 22x22mm coverslip scale 
hybridizations (Thermo Fisher Scientific, MNJ-350-020H) 5µg salmon sperm 
DNA (Sigma, D7656) and 10µg  human Cot1 DNA (Invitrogen, 15279-011), 
which were previously mixed in 30µl 100% EtOH and dried with the DNA 
Speed Vac (DNA 110, Savant), were dissolved in 8µl hybridization buffer 
(CamBio, provided with chromosome paints) and the mixture vortexed for 
10sec 3 times every 5 min before 2.5 µl chromosome paints were added. 
The complete hybridization mix was vortexed for 10 sec 3 times every 5 min 
and then put into the 80°C water bath for 5 min in order to denature the DNA. 
The denatured hybridization mix was placed into a 37°C waterbath for 15 
min. Preheated cell-containing slides were hybridized to biotin-labelled 




coverslip was sealed on the slide with Fixogum rubber cement (Marabu 
GmbH & Co. KG, Germany, 290110000) and the slide was placed into an 
aluminium foil covered metal plate floating in the 37°C water bath for 48h.   
After two days of hybridization the rubber cement was carefully 
removed from the coverslips and the slides were put into 37°C preheated 2x 
SSC for 5 min so that the coverslip would come off. Slides were then washed 
4x 3 min in 2x SSC at 45°C then 4x 3 min in 0.1x SSC at 60°C with slight 
shaking once every minute, then pre-equilibrated in 4x SSC, 0.1% Tween-20 
and blocked in 2%BSA/4xSSC/0.1 Tween20/PBS for 10 min at room 
temperature before incubating with avidin or digoxigenin antibody (Roche). 
DNA was visualized with DAPI (4,6-diamidino-2 phenylindole, 
dihydrochloride) and coverslips mounted in Fluoromount G (EM Sciences). 
 
2.2.4.5 FISH on human biopsy tissue sections2 
Human tissue sections were provided by Professor David J. Harrison 
(Western General Hospital, Edinburgh, UK) and obtained according to 
University of Edinburgh Ethics protocols. Tissues were formalin fixed, paraffin 
embedded and sectioned at 5-6 µm thickness onto slides. Sections were 
subsequently prepared for whole chromosome painting as below.  
For deparaffinization, tissues were heated in the oven at 70°C to melt 
the wax. After heating, sections were put straight into 100% Xylene for 10 
min at 45°C, followed by 3 additional incubations in 100% Xylene for 10 min 
each at 37°C. After the Xylene steps sections were put 4x10 min into 100% 
Ethanol, followed by 2x 5 min incubations in 95% Ethanol and 2x 5 min in 
70% Ethanol at room temperature, respectively. For complete rehydration 
tissue sections were put into deionized water for 5 min.   Cells were then 
permeabilized with 1 M Na isothiocyanate (in H2O) at 80°C for 30 min 
followed by 50 µg/ml pepsin (Sigma P-6887) in 0.01 N HCl at 37°C for 45 
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min. Cells were then dehydrated with an EtOH series and whole 
chromosome painting was performed as above. 
 
2.2.4.6 Image generation, image processing and statistics 
TIFF files were generated using Metamorph (Molecular Devices) or SP5 
application suite (Leica) and exported into ImageProPlus at 12 bit for further 
analysis. Images were also directly imported into Adobe Photoshop CS for 
figure preparation, reducing them to 8 bit. 
To determine if two datasets compared are different from one another the 
Kolmogorov-Smirnov test (KS-test) was applied. 
 
2.2.4.7 Algorithm for dividing the nuclear area into 5 concentric rings 
The algorithm that divides nuclear area into 5 concentric rings is based on an 
erosion script originally written by Paul Perry (Human Genetics Unit, MRC, 
Edinburgh) for IPLab Software. The principal of sequentially eroding from all 
edges 20% of the nuclear area was used for a new script written by Dr. David 
Kelly (Wellcome Trust Centre for Cell Biology, UK) to allow analysis with the 
ImageProPlus Software (Media Cyberkinetics, USA). For this script the total 
nuclear area must first be manually established by setting a threshold based 
on DAPI staining. The detailed script for this algorithm is provided in the 







2.2.4.8 2D and 3D chromosome positioning analysis algorithms3   
The 2D algorithm erodes the area of the nucleus based on the DAPI 
signal into 5 concentric rings of roughly same area. Subsequently this 
algorithm loads the image of the chromosome staining for the same nucleus 
and the total signal intensity of the chromosomes in this nucleus is set to 
100%. Subsequently, the algorithm allocates the proportion of the 
chromosome signals in each of these rings and gives an output of the 
percentage of the total chromosome signal for each ring. 
The 3D algorithm works basically like the 2D version, except that it 
erodes the nuclear volume from 3-dimensional reconstructions of the cell 
nucleus from z-stacks. This algorithm erodes the nuclear volume into 6 shells 
of roughly same volume and allocates the signal proportion of the 
chromosome in each individual shell. The detailed scripts for both algorithms 
are provided in the Appendix section. 
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Targeting of membrane proteins 
to the INM is mediated by 
multiple mechanisms 
 
Historically INM proteins were considered to move from the ER, where 
they are synthesized, to the ONM from where they further diffuse laterally 
through the peripheral channels of the NPC into the INM (Soullam and 
Worman, 1995). Later, separate findings suggested ATP- or Ran-
dependence for translocation of INM proteins. These studies, however, did 
not distinguish whether there was one complex mechanism that utilizes both 
Ran and energy or if the two function in separate translocation pathways 
because the substrates and organisms used were so different. This chapter 
aimed to test this by analyzing a wider range of INM proteins and comparing 
their dependence on these requirements using FRAP as the method of 







3.1 How to study membrane protein translocation into 
the nucleus? 
Many previous studies using FRAP to investigate transport of NETs 
have yielded distinct results. This could mean that several distinct 
mechanisms function for different cargoes that were used in each study. 
Furthermore, these differences in results could be due to the fact that the 
mechanism is just too complex and the many steps included have not been 
worked out. Another possibility is that each individual study used different 
variable parameters such as cell lines and imaging settings (some 
parameters of previous studies on NETs emerin, LAP2β and MAN1 are 
summarized in table 6). 
Table 6. Parameters of previous FRAP studies on NE protein mobility of 
emerin, LAP2β and MAN1 
NET 
studied 
t1/2 [s] Cell line used 





~60 COS-7 ~30% (Ostlund et al., 1999) 
~90 BHK ~20% (Rolls et al., 1999) 
~60 HeLa ~2% (Shimi et al., 2004) 
 
LAP2β 
~100 BHK ~20% Rolls et al., 1999 
~55 HeLa ~2% Shimi et al, 2004 
 
MAN1 
~100 BHK ~20% Rolls et al., 1999 
~50 COS-7 ~20% (Wu et al., 2002) 
  
I also used FRAP to study translocation of NETs into the INM. Earlier, 
my supervisor made the observation that when bleached in the NE, 
fluorescence from GFP-tagged NETs was recovering slower in cells with little 
NET protein in the ER but fast in cells that had high NET accumulation in the 




FRAP experiments was mainly due to NETs coming from the ER rather than 
from NETs that diffused from unbleached parts of the NE. While this 
observation was also suggesting that FRAP in the NE is likely to 
predominantly measure ER to INM translocation but it needed to be tested 
first as done by GFP-photoactivation and immunoelectron microscopy as 
described later in this chapter.   
To circumvent variability due to imaging and other experimental 
parameters I conducted a study where 15 INM proteins4 were investigated by 
means of FRAP using constant parameters. For FRAP, the fluorescence 
recovery was measured before, during and after the laser bleach in the NE 
(Figure 14, A, upper panel) to generate fluorescence recovery curves (Figure 
14, A, lower panel). Recovery halftimes were calculated from normalized 
fluorescence values, while the immediate post-bleach value was set to 0% 
and the average of the ten last points of recovery curve to 100%. Within this 
this mobile fraction range of the recovery curves the t1/2 was generated 
(please see Methods Chapter for details) as a measure for protein mobility in 
the NE.  
The tested NETs displayed a wide range of mobilities in the NE 
suggesting the possibility that different translocation mechanisms can apply 
for individual NETs (Figure 14, B). I also assessed NET mobilities in the ER, 
all of which were higher than the ones when bleached in the NE. A faster 
mobility of NETs in the ER is expected as in theory diffusion of NETs in the 
ER should be completely unhindered and match that of completely free 
diffusion in a membrane. In contrast, NE mobility should be slowed because 
of a potential gating process for translocation and NET interactions with 
nuclear components after the translocation. Though the mobilities in the ER 
were faster than in the NE for all proteins the ER mobilities between NETs 
varied suggesting that free membrane diffusion does not apply to all of them 
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thus arguing that NETs with slower mobility in the ER could exhibit additional 
functions in the ER.  
Indication for measuring translocation of NETs by NE FRAP is 
provided by the fact that a known ER resident protein, Sec61, displays 
similar mobility rates in both ER and NE as most of this protein is expected to 
reside in the ER or in the ONM (evidence for this will be provided later in this 
chapter) and accordingly no gating process into the INM during translocation 
or binding in the INM, which is the case for actual INM proteins, should slow 






Figure 14. Wide range of NET recovery rates in the NE. (A) HeLa cells 
expressing NETs fused to GFP are bleached in the NE and the fluorescence 
recovery in the bleached area is monitored. Displayed are three NETs with different 
recovery rates: LAP1, SUN2 and NET51. Recovery was very slow LAP1, medium 
for SUN2 and fast for NET51. The recovery curves for ER and NE FRAP are 
displayed below. (B) The recovery half times for all tested NETs were calculated. 
NETs displayed a wide range of recovery rates. The ER protein Sec61 (inbox) 
displayed similar recovery rated in both NE and the ER. Error bars indicate standard 





In addition to the recovery half-times I also assessed the mobile 
fractions of NETs in ER and NE (Figure 15). In FRAP experiments the 
fluorescence is often not recovering completely to pre-bleach levels. 
Assuming there is no protein aggregation or photobleaching during the 
recovery, the immobile fraction is due to a portion of the protein pool that is 
tightly bound and therefore highly immobile. The mobile fraction can be 
calculated by subtracting the % immobile fraction from the pre-bleach levels 
(100%). In the NE the NETs tested show a wide range of mobile fractions 
with LAP1-L being the most immobile NET while other NETs show more 
mobility with mobile fractions of 50-95%. It is striking that the five NETs with 
lowest mobile fraction (LAP1-L, LAP2, SUN2, LBR and LAP1-S) are widely 
characterized proteins that are known to have a wide range of binding 
partners in the nucleus. As expected, the mobile fractions in the ER were 
higher for all tested NETs (Figure 15).     
 
Figure 15. Mobile fractions of NETs in the NE and the ER as assessed 
by FRAP experiments. The tested NETs display a wide range of mobile 
fractions. In the NE LAP1-L shows very low levels of mobility (~25%) while all other 
tested NETs have mobile fractions between 50 and 95%. In the ER all NETs display 







The results up to this point were generated during my Master’s work 
and all remaining results reported are part of my PhD work. 
 
3.2 FRAP in the NE is predominantly measuring ER-
INM translocation 
To further investigate whether the observed recovery in the NE during 
NE FRAP is not primarily due to general protein movement within the NE but 
rather movement from the ER into the NE the two possibilities were dissected 
by means GFP photoactivation (PA). The application of PA-GFP allows 
visualizing particular parts in the living cell and to detect the movement of this 
visualized protein pool. Hence, we can photoactivate a section of the NE and 
measure whether the protein stays tethered or moves and we can 
photoactivate in the ER and see if the protein accumulates in the NE.  For 
this 5 NETs were fused to PA-GFP and cells expressing these fusions were 
analyzed. To discriminate the NE-NE movement NETs were activated in one 
part of the NE and the fluorescence accumulation in the non-activated part 
was detected (Figure 16, left). If the fluorescence recovery in FRAP 
experiments was primarily due to movement of protein within the NE, then 
the activated material must relatively quickly distribute from the activated part 
of the NE into the non-activated part of the NE. For measuring the ER-NE 
translocation step NETs were activated in the ER and the fluorescence 
accumulation in the NE was observed (Figure 16, right). If the fluorescence 
recovery in FRAP experiments was due to ER-NE translocation, then in PA 
experiments material activated in the ER should quickly accumulate in the 
NE and these accumulation kinetics should be similar to the NE FRAP 
recovery and should be much faster than movement within the NE during PA 





Figure 16. Schematic of the photoactivation (PA) experiment in order to 
distinguish NE-NE movement from ER-NE translocation. HeLa cells 
expressing PA-GFP-NET fusions were photoactivated in particular regions and the 
dispersion of the fluorescence monitored. Left: NETs were activated in one portion 
of the NE and the fluorescence distribution into the non-activated part of the NE was 
measured. Right: NETs were photoactivated in the ER and the fluorescence 
dispersion into the adjacent part of the NE was measured. (Figure adapted from 
Zuleger et al., 2011a) 
 
Intriguingly, when activated in the NE only, NET37 and LAP2 exhibited 
extremely slow movement towards the non-activated part of the NE 
suggesting extremely low mobility within the NE per se (Figure 17, first and 
third column). This also means that in FRAP experiments in the NE the 
fluorescence recovery cannot be due to movement within the NE. When 
photoactivated in the ER, however, a quick accumulation of both NET37 and 
LAP2 in the NE was observed (Figure 17, second and fourth column) 
meaning that in NE FRAP the recovery is likely mainly due to movement from 
the ER into the NE. Hence, NE FRAP is likely to measure ER-NE 








Figure 17. PA experiments distinguish NE-NE movement from the ER-
NE translocation. NETs were fused to a photoactivatable version of GFP and 
expressed in HeLa cells. PA-GFP-LAP2 or NET37 fusions were activated in one 
portion of the NE (first and third column) and fluorescence intensity was measured 
in the non-activated portion of the NE. Additionally NETs were activated in the ER 
and the fluorescence was measured in the non-activated NE portion proximal to the 
activated ER area (second and fourth column). While the distribution of fluorescence 
(and therefore NETs) was very slow when activated in the NE (first and third 
column), the fluorescence accumulation in the NE was very fast when NETs were 
activated in the ER (second and fourth column). Scale bars are 5μm. (Figure 




In addition to NET37 and the LAP2 same PA experiments were 
performed on NET51, NET55 and emerin and the measurements from 
several repeats quantified and averaged (Figure 18). The results again 
indicated that NET movement within the NE is minimal (black line; after the 
activation of one portion of the NE the signal accumulation in the non-
activated NE portion is small as indicated by the small slope); however the 
mobility of NETs during translocation from the ER into the NE was high (grey 
line; the NE signal accumulation after the activation in the ER is high as 
indicated by the comparatively large slope). This result strongly supports the 
idea that most of the recovery during FRAP experiments is not due to 
movement within the NE itself but rather due to translocation of NETs from 





Figure 18. ER-NE translocation is faster than NE-NE movement 
(Quantification of PA experiments as described in figures 16 and 17). 
Fluorescence accumulation was measured in the non-photoactivated NE area after 
photoactivation in either the NE (black) or the ER (grey) (see figure 16 for details). 
While fluorescence accumulation in the NE was very rapid and intense after PA in 
the ER (grey), the NE-NE fluorescence movement was barely evident for all tested 
NETs (black). Fluorescence values are in arbitrary units and are normalized. Error 
bars indicate standard deviations from 3-7 individual experiments. (Figure adapted 





The table below summarizes the t1/2s of slow NET diffusion within the NE in 
PA experiments and the much faster recovery kinetics of the same NETs in 
the NE during FRAP experiments. The t1/2s for ER-NE translocation as 
measured by PA are also presented and are roughly matching the kinetics in 
NE-FRAP again supporting that NE FRAP is predominantly measuring ER-
NE translocation. 
Table 7. NE FRAP t1/2s and t1/2s for ER-NE translocation and NE-NE 
movement as measured by PA 
NET FRAP: NE t ½ 
[s] 
PA: ER-to-NE t ½ 
[s] 
PA: NE-to-NE t 1/2 
[s] 
NET37 19.3 ± 5.5 27.8 ± 5.0 NA* 
NET51 7.1 ± 2.2 7.0 ± 2.1 70.9 ± 32.2 
NET55 14.9 ± 4.6 17.7 ± 9.0 47.6 ± 18.5 
emerin 20.3 ± 3.8 12.0 ± 4.2 56.8 ± 23.0 
LAP2 25.0 ± 1.6 14.6 ± 6.1 70.2 ± 52.9 
* No t1/2 could be calculated for NET37 in NE-NE photoactivation because  
it exhibited too little movement 
 
Given the results above I am reasonably confident that most of the 
recovery in FRAP experiments in the NE is mainly due to ER-NE 
translocation rather than redistribution within the NE. However, it should be 
noted that due to the fact that the NET proteins are exogenously 
overexpressed in FRAP experiments, several additional pools are likely to 
impact the recovery behaviour in the NE. One such pool, for instance, is the 
mobile pool in the INM membrane, which arises from saturation of binding 
sites for the NET in the INM due to NET overexpression. There is also the 
highly immobile pool in the INM, which is the reason for the immobile fraction. 
This immobile pool is blocking the diffusion of molecules from the ER to the 
INM. There is another NET pool that is diffusing from the ER into the ONM 
and one more pool that is translocating from the ONM into the INM. Our PA 




neglected as there is hardly any movement within the NE but in NE FRAP 
experiments recoveries for most NETs exceed the 80% pre-bleach intensities 
meaning that recovery must be principally due to ER-NE translocation. Thus 
only the ER-ONM pool can skew our INM translocation measurements by 
FRAP. As explained in the following example. If most NET molecules are in 
the ONM rather than INM and we see over 80% fluorescence recovery after 
the photobleach for most NETs in the NE, than what we would measure by 
NE FRAP is movement from the ER in to the ONM but not translocation from 
the ER over the ONM into the INM.  However, when most of the NET 
molecules are in the INM but not the ONM then high fluorescence recoveries 
in the NE after bleaching could not possibly be due to ER-ONM movement 
but must be due to translocation from the ER over the ONM into the INM. 
Thus, I needed to test whether most of the NET material is in the INM or 
ONM.   
The spatial resolution of FRAP and PA is not sufficient to distinguish 
between the INM and ONM, thus I measured the distribution of NET-GFP 
fusions between the INM and ONM by immunogold labelling of the NETs with 
GFP antibodies and subsequent analysis by electron microscopy5. This 
revealed that the INM harboured the majority of material for all NETs tested 
(Figure 19). We also tested the INM/ONM distribution of the ER control 
protein Sec61β6, which as expected, had most of its material (93%) in the 
ONM and only 7% in the INM, also meaning that exogenous overexpression 
of an ER protein does not result in its subsequent accumulation in the INM. 
The high proportion (~55-80%) of NET accumulation in the INM also meant 
that the fluorescence recovery in FRAP experiments cannot be due solely to 
ER-ONM movement because in that case NETs would not recover to 80% 
(and higher) pre-bleach fluorescence levels but would recover to maximally 
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45% as this is the maximum percentage of molecules in the ONM we 
measure for GFP-NETs.  
 
Figure 19. Electron microscopy reveals the ONM and INM distribution of 
exogenously expressed GFP-NETs. (A) Electron micrographs of NET fusion 
proteins labelled by 5nm gold particles (black spots). NETs display a bigger 
proportion of gold particles in the INM compared to the ONM whereas the ER 
control protein Sec61β has more gold particles in the ONM than in the INM. 
Downward arrowheads mark the ONM and upward arrowheads mark the INM. The 
nucleoplasmic and cytoplasmic faces are indicated with N and C, respectively. Scale 
bar is 100nm. (B) Quantification of the gold particle counts in the inner (dark grey) or 
outer (light grey) nuclear membrane for each NETs tested. The numbers of total 
gold particles counted for each protein are indicated next to each sample. (Figure 




Based on the above observations, I will be using the term 
“translocation” for movement from the ER into the INM of the NE even 
though I acknowledge that NE FRAP (and likewise PA in the ER and the 
subsequent accumulation of the signal in the NE) is measuring the 
translocation predominantly but not exclusively. 
 
 
3.3 Distinct translocation requirements for distinct 
NETs  
Having determined that FRAP in the NE for this set of NETs was 
principally measuring the translocation step from the ER-INM, we could use 
this method to further test the different requirements reported for the 
translocation of NETs. These experiments will also determine whether the 
different requirements reported previously apply to all of our NETs. For 
testing specific requirements of NET translocation by FRAP we reduced the 
number of NETs to six. These six NETs were representing proteins with 
different characteristics such as total protein size, size of the nucleoplasmic 
domain, NLS prediction score and total number of transmembrane spans. 
First, we tested if ATP is a requirement for NET translocation as 
reported by the Gerace laboratory (Ohba et al., 2004). For this cells were 
depleted of ATP and analyzed by FRAP in the NE (Figure 20). Cells not 
depleted for ATP served as controls. Among the six tested NETs only 
translocation of SUN2 and emerin was impaired by ATP depletion. The 
mobile fraction of SUN2 decreased so much that an accurate t1/2 could not be 
calculated (asterisks). For emerin the mobile fraction also decreased by more 
than 2-fold resulting in the doubling of the t1/2. All of the other four NETs 





Figure 20. SUN2 and emerin require ATP for translocation. FRAP 
experiments in the NE were performed in medium depleted for ATP and compared 
to non-depleted control cells. The t1/2s are presented in the top panel and the mobile 
fractions in the bottom panel. The mobility of NET51, NET55, LBR and LAP2 were 
not affected by ATP depletion but both SUN2 and emerin had a visibly inhibited 
mobility under depletion conditions. For emerin the t1/2 doubled and the mobile 
fraction dropped by 2-fold whereas for SUN2 the mobile fraction dropped to such an 
extent that a t1/2 value could not be accurately determined (asterisks). Error bars 
indicate standard deviation from at least 8 individual experiments. (Figure adapted 
from Zuleger et al., 2011a) 
We next aimed to test if the nucleoplasmic region of emerin (1-224aa) 
is required for its ATP-dependent translocation into the INM. This was the 
most likely case since this region is the most accessible (more accessible 
than the luminal region) for proteins and other binding factors. For this the 
nucleoplasmic emerin region was fused to NET51 and LBR, two proteins that 
did not required ATP as wild-type counterparts. Wild-type emerin and NET55 
were used as positive and negative controls, respectively. The proteins were 
analyzed by FRAP in the NE with and without ATP depletion. Like wild-type 
emerin also NET51 and LBR acquired ATP dependence when fused to the 
nucleoplasmic region of emerin meaning that the nucleoplasmic domain of 
emerin is required its ATP-dependent translocation. NET55 served as 
negative control since it was not affected by ATP depletion in previous 





Figure 21. The nucleoplasmic domain of emerin is required for its ATP-
dependent translocation. The nucleoplasmic region of emerin (1-224aa) was 
fused to NET51 and LBR, two proteins that do not require ATP for nuclear 
translocation. These chimeric constructs were tested by FRAP in the NE upon ATP 
depletion and compared to wild-type emerin and NET55. The t1/2s are presented at 
the top and the mobile fractions at the bottom. When fused to the nucleoplasmic 
region of emerin both NET51 and LBR are conferring ATP dependence to a similar 
extent as the wild-type emerin although the mobile fractions for both chimeric 
constructs are higher than that of wild-type emerin. Wild-type NET55 served as a 
negative control and was not affected by ATP depletion. Error bars indicate standard 
deviation from at least 8 individual experiments. (Figure adapted from Zuleger et al., 
2011a) 
Importantly, we also tested if ATP was required for NET mobility within 
the ER as the recovery in the NE could potentially also be impaired due to 
slower protein movement in the ER. To answer this, FRAP experiments upon 
ATP depletion were performed on emerin and SUN2 in the ER and compared 
to ATP non-depleted control cells (Figure 22). NET51 served as a negative 
control. Like in the NE, emerin and SUN2 displayed ATP dependence in the 
ER while NET51 was unaffected. Thus ATP in some way facilitates ER 





Figure 22. Emerin and SUN2 require ATP also for the mobility within the 
ER. Fluorescence recovery for emerin, SUN2 and NET51 was measured after 
photobleaching in the ER with and without ATP depletion. Both emerin and SUN2 
were affected by depletion whereas NET51, which served as a negative control, was 
not. Error bars indicate standard deviation from at least 8 individual experiments. 
(Figure adapted from Zuleger et al., 2011a) 
 
Next, we tested if Ran-GTPase activity is required for NET 
translocation from the ER into the INM, a requirement that was suggested by 
the Blobel laboratory (King et al., 2006). For this, a dominant negative 
RanQ69L mutant of Ran was co-transfected with GFP-NETs and cells were 
analyzed by FRAP in the NE (Figure 23). Since Ran is small, only ~25 kDa, it 
is likely to lose its function when fused to a big fluorescent tag like GFP.  
Thus, we created a plasmid construct that was coding for untagged Ran and 
additionally for an mRFP reporter that was driven by a separate promoter. 
The expression of the Ran mutant was confirmed by both Western blotting 
and indirect immunofluorescence (Figure 23, A). Of the six proteins tested 




(Figure 23, B). The t1/2 of LBR more than doubled compared to Ran non-
depleted control cells (Figure 23, B upper panel). Interestingly, the mobile 
fraction of LBR was hardly affected by Ran function depletion (Figure 23, B 
bottom panel). 
 
Figure 23. Depletion of Ran function affects LBR translocation. FRAP 
experiments were performed in HeLa cells expressing NETs upon Ran GTPase 
function depletion and compared to non-depleted control cells. Ran function was 
depleted by co-expression of the dominant negative mutant RanQ69L. (A) Left 
panel: Confirmation of the Ran mutant expression by western blotting, actin was 
used as a loading control. Right panel: Confirmation of the Ran mutant expression 
by immunofluorescence. The bottom cell expresses the mRFP as an expression 
marker for the Ran mutant. The mRFP gene is on the same plasmid as the Ran 
mutant but driven from a separate promoter because Ran function is sensitive to 
ectopic tags. The bottom cell showing the mRFP expression also confirms higher 
Ran staining compared to the untransfected control cell. (B) Only LBR fluorescence 
recovery after photobleaching is affected when Ran function is depleted. The 
recovery half time of LBR doubled compared to the wild-type control. Error bars 
indicate standard deviation from at least 8 individual experiments. (Figure adapted 





There is a possibility that proteins that were neither affected by ATP 
nor by Ran function depletion are actually able to use both pathways and in 
the case of depletion of one mechanism the other pathway would rescue the 
depletion effect. To test this we depleted both ATP and Ran function 
simultaneously (Figure 24). Like with depletion of ATP or Ran alone 
translocation was affected only for LBR, SUN2 and emerin. Interestingly, 
depletion of ATP and Ran together yielded no greater reduction in 
translocation than either alone for any of the three proteins that required one 
or the other for translocation.   This indicates that ATP- and Ran-dependent 
translocation pathways occur separately from each other. ATP and Ran 
function double-depletion did not affect translocation of NET51, NET55 and 
LAP2. Thus for these three proteins we can exclude the scenario that upon 
single depletion of the ATP pathway, for example, the Ran pathway is 
rescuing the translocation.   
 
Figure 24. ATP and Ran requirement pathways for NET translocation 
act independently from one another. HeLa cells were subjected to FRAP upon 
depletion of both ATP and Ran and compared to untreated control cells. NET51, 55 
and LAP2 were not affected by the double depletion. Depletion of ATP and Ran did 
not affect the LBR translocation stronger than depletion of Ran function alone (black 
bar, §). SUN2 and emerin were affected by double depletion to the same level as by 
ATP depletion alone (black bars, #). No accurate t1/2 could be calculated for SUN2 
due to a strong drop in the mobile fraction (asterisks). Error bars indicate standard 






3.4 Ran-mediated translocation is independent of 
NLSs or FGs 
Since LBR was the only tested NET affected by Ran we searched for 
specific LBR characteristics that distinguish it from the other tested NETs, 
because these characteristics could be the determinants for Ran function 
requirement during translocation. One such striking characteristic of LBR was 
the presence of many nuclear localization sequences, short NLSs. The three 
strongest NLSs out of four are located between 1-128 aa of the LBR (as 
predicted by the pSORTII algorithm, the NLS prediction score for this LBR 
region is 1.19). Testing if NLSs are determinants of the Ran pathway could 
be done either by fusing the LBR-NLSs to proteins that do not have any or by 
mutating the NLSs in the LBR sequence. Since the latter is likely to result in 
the disruption of the LBR’s structure we went ahead with the first option. 
Therefore we fused this LBR-NLS region to NET51, NET55 and emerin, all of 
which did not confer Ran function dependence. Additionally these three 
proteins were separately fused to the classical SV40NLS. The NLS prediction 
scores before and after fusion to the NLSs are provided in the table 8.  
Table 8. NET51, NET55 and emerin NLS scores before and after fusion to 
LBR-NLS or SV40 NLS 
NET wild-type NET+ LBR-NLSs NET+ SV40-NLS 
NET51 -0.22 1.20 1.52 
NET55 -0.47 0.94 1.27 
emerin 0.02 1.44 1.76 
Note: The NLS prediction score for LBR is 1.19 
 
All these fusions were analyzed by FRAP upon Ran function depletion 
(Figure 25, A). None of the NLS-fusion NETs were affected by Ran function 





As the wild-type NETs were unaffected by Ran depletion they must 
have other mechanisms for translocation and these mechanisms might allow 
for translocation even if the additional NLSs contributed a possible Ran 
component. Thus a better experiment would be to fuse an NLS to a non-INM 
protein, for example an ER protein, and test then if Ran function depletion 
would interfere with translocation into the INM. To do this we fused the 
classical SV40NLS to the ER protein Sec61β. While the wild-type Sec61β 
localized strongly to the ER and to some minor extent also to the NE, the 
NLS-fused version of this protein localized mainly to the NE as shown by 
immunofluorescence (Figure 25, B upper panel). At higher resolution 
Immuno-EM confirmed that wild-type Sec61β is accumulating preferentially in 
the ONM while the SV40NLS-fused version resides mainly in the INM (Figure 
25, B lower panel). However, when analyzed by FRAP neither wild-type 
Sec61β nor Sec61β-NLS were affected by Ran function depletion (Figure 25, 





Figure 25. Ran-mediated translocation is not dependent on nuclear 
localization sequences (NLS). (A) The first 128 amino acids of LBR containing 
three putative NLSs (as predicted by the NLS prediction algorithm pSORTII) or the 
SV40NLS were fused to NET51, 55 and emerin, three proteins that did not require 
Ran function as wild type counterparts. When tested upon Ran depletion conditions 
none of the chimeric fusion proteins confirmed inhibition in translocation. LBR 
serving as a positive control did show an inhibited translocation. (B) Localization of 
the ER protein Sec61β wild-type and its counterpart, which was fused to the 
classical SV40NLS by immunofluorescence (top panel) and electron microscopy 
(bottom panel). Wild-type Sec61β localizes exclusively to the ER membranes and 
the ONM whereas the SV40NLS-Sec61β localizes mainly to the INM. (C) Sec61β 
wild-type and SV40NLS-Sec61β were analysed by FRAP upon depletion of Ran. No 
inhibition in translocation was observed for either protein while the positive control 
LBR was affected in its translocation. Error bars indicate standard deviation from at 




Even though the translocation kinetics of the Sec61β-NLS construct 
were not affected by Ran depletion, the distribution of molecules between the 
ONM and INM might have changed under this condition making an effect 
invisible by FRAP. Therefore we used immunoelectron microscopy to check 
for the potential change in the distribution of the constructs with and without 
Ran function depletion (Figure 26). As already described wild-type Sec61β 
had about 95% of its material in the ONM, but when fused to the classical 
SV40NLS this protein accumulated about 80% of its material in the INM. Ran 
depletion only slightly reduced the INM accumulation to ~75%. The same 
observation was made for LBR. About 75% of LBR molecules reside in the 
INM under normal conditions but when Ran function is depleted the INM 
accumulation slightly drops to ~70%. Together with the previous 
observations of NLS-chimeras upon Ran function depletion this data 








Figure 26. NE distribution of Sec61β, NLS-Sec61β and LBR with and 
without Ran function depletion. The INM and ONM distribution of the Sec61β, 
NLS-Sec61β and LBR was assessed by electron microscopy micrographs of 30-50 
individual cells. The amount of total gold particles counted is indicated on top of 
each sample. The percentage of gold particles in the INM is labelled in black and 
percentage in the ONM in gray. About 5% of Sec61β are residing in the INM 
whereas when the SV40NLS is added to this protein the gold particle percentage 
goes up to ~80%. Upon Ran function depletion the percentage of NLS-Sec61β goes 
slightly down to ~ 75%. About 75% of LBR reside in the INM under non-depleted 
conditions but when Ran function is depleted, this percentage goes also slightly 
down to ~70%. (Figure adapted from Zuleger et al., 2011a) 
 
Since NLSs did not confer Ran-dependent INM protein translocation 
we searched for further LBR characteristics that distinguish it from the other 
NETs.  One such characteristic was a high number of phenylalanine/glycine 
(FG)-repeats in the LBR sequence. This amino-acid pairing is not very 
common as only 1.5% of all human proteins posses six or more FGs (Zuleger 
et al., 2011a). FGs occur in nucleoporins and transport receptors (for 




the transport of soluble cargoes into the nucleus via the central channel of 
the NPC (Rexach and Blobel, 1995) though clear experimental data for this 
hypothesis is still missing. LBR has six FGs while NET51 has one and 
NET55 has four. Since both NET51 and NET55 did not show any Ran 
depletion dependence both were fused to a short artificial sequence 
containing four FGs (MFGHTFGFGQSVFG) and these constructs were 
tested by FRAP with and without Ran function depletion7 (Figure 27). LBR 
serving as a positive control exhibited Ran dependence while neither NET51 
nor NET55 when fused to the FG-sequence were affected. Thus, Ran 
function dependence does not seem to depend on FGs either. 
 
Figure 27. Addition of Phenylalanine-Glycines (FGs) does not confer 
Ran-dependence for translocation of NETs into the INM. An FG-containing 
sequence (MFGHTFGFGQSVFG) was fused to NET51 and NET55. These 
constructs were analyzed by FRAP in the NE with and without Ran function 
depletion. Neither NET51:FG nor NET55:FG was inhibited by Ran function depletion 
unlike LBR, which was used as a positive control. Error bars indicate standard 
deviation from at least 8 individual experiments. (Figure adapted from Zuleger et al., 
2011a) 
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3.5 FGs are enriched in INM proteins and facilitate 
their translocation 
Though FGs did not confer Ran-dependent INM translocation, we 
observed that when NET51 and NET55 were fused to the four FG-containing 
sequence, the translocation occurred significantly faster than that of their 
wild-type analogues (Figure 28) suggesting that FGs could play a role in 
translocation of NETs into the INM. 
 
Figure 28. Addition of FGs enhances translocation of INM proteins. 
FRAP dynamics in the NE were tested for wild-type NET51 and NET55 and their 
FG-containing sequence fused counterparts. Both NET51:FG and NET55:FG had 
faster recovery kinetics than their wild-type analogues and therefore translocate 
faster into the INM. Error bars indicate standard deviation from at least 12 individual 
experiments. The p-values are indicated on top of each pair. (Figure adapted from 
Zuleger et al., 2011a) 
 
As mentioned above FGs are not very common in protein sequences 




NETs in general. We searched 199 predicted NETs found in a proteomic 
data set from rat liver (Schirmer et al., 2003) and compared them with all 
transmembrane proteins coded by the rat genome8 (Figure 29, A). Strikingly, 
the occurrence of 12 or more FGs in the NE dataset was enriched compared 
to the total membrane protein set (Figure 29, A). The enrichment of FGs was 
also highly significant when comparing the same NE membrane protein data 
set with all membrane proteins found in a different organelle, the 
mitochondrion (Figure 29, B) indicating that presence of FGs is a special 
characteristic of membrane proteins destined for the nucleus but not 
membrane proteins of other organelles. 
 
Figure 29. FGs are enriched in NETs.  (A) 199 predicted NETs from a rat liver 
proteomic study were searched for FGs in their soluble domains (predicted 
membrane domains were excluded) and compared to soluble domains of all 
membrane proteins encoded by the rat genome. These two data sets were plotted 
for their occurrence of FGs. It is evident that the percentage of membrane proteins 
having 12 or more FGs in the NE data set is higher than in the total membrane 
protein set. (B) Occurrence of FGs was compared between the 199 predicted NETs 
from the same rat liver proteomic study and all membrane proteins found in 
mitochondria. The NET dataset is more enriched for multiple FG-containing proteins 
than the mitochondrial membrane protein dataset. The p-value for the difference 
significance is indicated. (Figure adapted from Zuleger et al., 2011a) 
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3.6 Ran- and FG-mediated pathways require Nup35 
The ability of the FGs to increase the translocation rates of NETs 
together with the observation that FGs are enriched in NETs opened the 
possibility that FGs in NETs might interact with FGs in nucleoporins to 
navigate the NPC channel as this is the proposed model for soluble proteins 
during nuclear transport (Rexach and Blobel, 1995). Recent structural 
refinements of the NPC suggest that some FG-containing nucleoporins 
reside in the peripheral channel of the NPC (Alber et al., 2007). One such 
nucleoporin is Nup35 (mammalian Nup35 is the homologue of yeast Nup53). 
To test if Nup35 is involved in INM translocation of NETs we depleted HeLa 
cells of Nup35 by means of siRNA (Figure 30, B) and analyzed NET 
translocation under the Nup35 depletion (Figure 30, A). Similar to Ran 
function depletion, only LBR translocation was significantly inhibited upon 
depletion of Nup35 (Figure 30, A). This result indicated that Ran and Nup35 
both might function in the same translocation pathway. To test this possibility 
LBR was subjected to simultaneous depletion of both Ran and Nup35 (Figure 
30, C). Upon double depletion LBR translocation was not more strongly 
inhibited than upon depletion of either Ran or Nup35 alone (Figure 30, C). 
This result is consistent with that both Ran and Nup35 might be part of the 
same NET translocation pathway.  
We further tested if the FG-facilitated pathway also depends on Nup35 
based on the previously mentioned hypothesis that FG Nups facilitate 
transport of FG-containing proteins. For this we analyzed wild-type NET51 
and NET51 fused to the FG-sequence with and without Nup35 depletion 
(Figure 30, D). Translocation of wild-type NET51 was not affected by Nup35 
depletion; however, when fused to FGs NET51 exhibited a decrease in 
translocation kinetics to levels of wild-type NET51 (Figure 30, D). This data 
suggests that the FG-facilitated translocation pathway is also dependent on 





Figure 30. Nucleoporin Nup35 affects translocation of some NETs (A) 
NET translocation kinetics were analyzed by FRAP with and without depletion of the 
nucleoporin Nup35. LBR was the only heavily affected protein upon Nup35 depletion 
(p-value indicated). (B) Western blot confirming efficient Nup35 depletion. Tubulin 
was used as a loading control. (C) LBR was tested with and without Nup35 
depletion. Depletion of Nup35 affected LBR translocation to a similar extent as the 
depletion of Ran function alone. LBR was not further affected when both Ran and 
Nup35 were depleted. (D) NET51 and its NET51:FG were tested in the Nup35 
depletion background. While NET51 wild-type was not affected by Nup35 depletion, 
NET51:FG translocation was inhibited. Error bars indicate standard deviation from at 








3.7 Summary of chapter 3 
In this chapter I used FRAP and GFP-PA to study the transport of 
NETs to the INM. By means of GFP-PA I was able to show that NET 
movement within the INM is restricted, however ER-NE translocation was 
rapid. This finding revealed that the relatively rapid recovery of NETs in the 
NE as measured by FRAP must be predominantly due to ER-NE 
translocation rather that NE-NE movement. Therefore I used FRAP as a 
method to study the translocation of NETs into the INM. I found that there 
was a wide range translocation rates within 15 tested NETs. I went on to test 
6 out of these 15 in further detail subjecting them to different conditions. I 
found that out of six NETs only emerin and SUN2 required ATP for 
translocation. Further, when Ran function was depleted only LBR 
translocation was impaired. Thus the possibility that all NETs require ATP 
and Ran in order to negotiate the NPC diffusion barrier could be excluded. I 
also found that both pathways are independent of one another. A further 
assumption previously established was that NLS-containing NETs require 
Ran function to translocate into the INM. Here I fused the classical SV40-
NLS or the LBR-NLS to NETs and found that the addition of the NLSs did not 
establish a Ran dependence. However, I found a new mechanism for 
translocation in which phenylalanine/glycines (FGs) in the protein sequence 
of NETs facilitated their translocation into the INM. When we looked at a 
larger NET dataset an enrichment for FGs was revealed.  Both the Ran and 
FG-facilitated pathways required a peripheral channel NPC protein Nup35 
though both pathways were independent of one another. The use of the 
Nup35 strongly argues for translocation of NETs through the peripheral 









NETs can reposition 
chromosomes to and from the 
nuclear periphery 
 
It is known that chromosomes of interphase cells are not randomly 
organized but tend to occupy particular regions, called chromosome 
territories (Cremer and Cremer, 2001; Parada and Misteli, 2002; Scherthan 
et al., 1996). These chromosome territories themselves are also specifically 
organized within the nucleus with some chromosomes being preferentially at 
the nuclear edge and others in the nuclear interior. To understand how these 
3D chromosome organizations are established, factors that can mediate such 
chromosome arrangements need to be identified. Because many 
chromosomes are close to the nuclear periphery it only follows logically that 
the NE could be one such factor. This idea was supported by recent findings 
where chromosomes could be tethered to the NE using exogenous high 
affinity systems (Finlan et al., 2008; Kumaran and Spector, 2008; Reddy et 





4.1 A screen to identify NETs that reposition 
chromosomes 
We hypothesized that INM proteins could affect positioning of 
chromosomes in interphase cells. Many of these proteins are tissue-specific 
and thus this characteristic could also explain why a particular chromosome 
is at the nuclear periphery in one tissue, but not the other. To find NE 
proteins that can reposition chromosomes to and from the nuclear periphery, 
we expressed a large set of them in 2 distinct cell lines, each marked for a 
specific chromosome9. The first cell line has a lacO integration in a 
euchromatic region on chromosome 5, the second cell line has the lacO 
locus integrated in a heterochromatic region on chromosome 13. The locus 
on chromosome 5 tends to be in the nuclear interior whereas the locus 
integration on chromosome 13 tends to be at the nuclear periphery. Loci in 
both cell lines are visualized by a GFP-fused lacI. Both cell lines are derived 
from human fibrosarcoma HT1080 cells and we previously tested our NE 
proteins for targeting in the HT1080 cell line (Malik et al., 2010). Three days 
post-transfection the lacO cells were analyzed for whether the position of the 
array had changed upon the expression of a particular NET. Analysis was 
performed three days post transfection to give the cells enough time to 
express the NET first and to let the cells go through mitosis since the lacO 
study from the Bickmore laboratory demonstrated that a cell has to go though 
one cell division to reposition a chromosome to or away from the nuclear 
periphery (Finlan et al., 2008).  
Images used for analysis were 2D planes from cell mid-sections. Only 
lacO array spots that were within the 2D plane midsections were counted. 
This allowed deducing with absolute confidence whether the lacO arrays 
were at the nuclear periphery or the nuclear interior (i.e. lacO spots on top of 
the nuclei at the NE would not appear in the mid-plane section). Since cells 
for this analysis were fixed in formaldehyde, the 3D structure of the cells was 
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maximally preserved allowing referring to the nuclear edge as the nuclear 
periphery (due to the preservation of the 3D structure lacO array signals on 
top of the nucleus are not captured by the 2D cell mid-section plane and 
therefore cannot appear as false-positive interior signals like it would be the 
case if the cells were fixed with Methanol/Acetic acid).         
The schematic below outlines a possible output of the screen on the 
example of the chromosome 5 integration cell line (Figure 31). 
 
Figure 31. Screen for NETs that can reposition a marked interior locus 
to the nuclear periphery. A human HT1080 fibrosarcoma cell line contains a 
lacO array, a bacterial DNA sequence that does not occur in the mammalian 
genome. To visualize this array the cell line also expresses a bacterial lacI repressor 
(fused to GFP), which has a high affinity to the lacO array thus marking it as a green 
spot within the nucleus. The array is located in the nuclear interior in interphase cells 
(on the left). The cell line is transfected with NETs, which are fused to monomeric 
RFP (red ring around the nucleus). Three days after transfection the cells are 
subject to microscopy analysis to determine if any of the NETs  repositioned the 
interior locus (green) to the nuclear periphery (upper cell on the right). 
 
To prevent bias in scoring whether the locus is at the periphery or not 
an algorithm was applied, which erodes the nuclear area based on the DAPI 




interior) of roughly equal areas10 allowing to score in which shell the lacO 
array is located for each individual cell nucleus (Figure 32). 
 
Figure 32. Algorithm for unbiased determination of the lacO array 
position. The algorithm recognizes the cell nucleus by the DAPI signal and erodes 
the nuclear area from the periphery towards the interior into 5 shells of roughly equal 
areas (1= most peripheral shell, 5= most interior shell), so that the lacO array (green 
spot) position can be allocated to a particular shell (in this case shell 2). 
 
Twenty-three NETs were screened in the cell line with the lacO array 
integration on chromosome 5. For initial statistical confidence fifty cells 
expressing each NET were imaged and analyzed with the erosion algorithm. 
In untransfected and mRFP transfected control cells the lacO array was in 
the most peripheral shell in 20% of the cells. Though most of the NETs had 
no or minor effects, others like NET5 (~45% at periphery), 29 (~35% at 
periphery), 39 (~45% at periphery), 45 (~35% at periphery) and 47 (~35% at 
periphery) increased the incidence of the array at the nuclear periphery by 
roughly 2-fold (Figure 33).  
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Figure 33. Some NETs can reposition the lacO array-containing 
chromosome 5. (A) NET29 and NET39 expressing cells show peripheral 
localization of the lacO array whereas in untransfected cells in the same micrograph 
the array remains in the interior (top and middle panel). The array location in the 
NET55 expressing cell is not altered compared to the untransfected cell in the same 
micrograph (bottom panel). Scale bar, 5µm (B) Quantification of the lacO array 
position using the algorithm described in Figure 32. Each bar represents the 
percentage of the lacO array scored in a particular radial shell in the nuclear area 
when analyzing 50 cells for each sample. The darkest blue bars represent the most 
peripheral shell with a gradient of lighter blue colours marking the more internal 
shells respectively. Quantification shows that NET5, 29, 39, 45 and 47 significantly 
increase the incidence of the lacO array at the nuclear periphery (~2-fold) compared 
to mRFP transfected and untransfected control cells. P values <0.0007 are marked 
by the asterisks and represent the confidence that the asterisks marked samples are 
different from the untransfected and the mRFP transfected controls as measured by 
the KS test.  
To test whether different NETs would have specificity for distinct 
chromosomes we tested the same set of NETs in a cell line where another 
chromosome, chromosome 13, was marked by the lacO array. In this cell line 




screening the NETs in this cell line three scenarios were observed. Proteins 
like NET5, and NET45 had no strong effect on the array position compared to 
mRFP transfected and untransfected controls. Others like NET24, NET47 
and NET49 decreased the incidence of the array at the NE (~1.5-2-fold) and 
yet others like NET29 and NET39 increased (~1.2-fold) the incidence at the 
periphery (Figure 34, B). It is important to note that whereas proteins like 
NET29 and NET39 were both relocating chromosome 5 and 13 to the NE 
others had only effect on one chromosome (for example NET5 or NET45) 
and yet others like NET47 had opposite effects in the respective cell lines 














Figure 34. Some NETs can reposition the lacO array-containing 
chromosome 13. (A) Schematic of the visual screen in the cell line where 
chromosome 13 is marked by a lacO array. The array is located in at the nuclear 
periphery in 50% of the cells and overexpression of NETs could increase this 
incidence (right upper panel) or decrease this incidence (right, lower panel) or leave 
the array incidence in the peripheral bin unchanged (left). (B) Quantitative analysis 
of the visual screen when scoring 50 cells for each sample with the erosion 
algorithm described in Figure 32. The darkest blue bars represent the most 
peripheral shell with a gradient of lighter blue colours marking the more internal 
shells respectively. The analysis shows that NET29 and NET39 increase the 
incidence of the lacO array at the nuclear periphery. P values <0.078 are marked by 
the asterisks and represent the confidence that the asterisks marked samples are 
different from the untransfected and the mRFP transfected controls as measured by 
the KS test. 
 
To obtain statistical confidence of array repositioning effects 5 NETs 
with strong effects and 2 NETs with no reposition effects were re-tested in 
both cell lines in two additional independent experiments along with the 
mRFP transfected and untransfected controls. The repositioning effects were 
reproducible confirming that NET5, 29, 39, 45 and 47 repositioned the array-
containing chromosome 5 to the nuclear periphery (~2-fold compared to 
controls) whereas in the chromosome 13 labelled cell line only NET29 and 
NET39 increased (~1.2-fold) the peripheral localization of the array. NET47 




NET55 as well as the mRFP transfected control cells did not alter the array 
position in either cell line (Figure 35).  
 
Figure 35. Conformation of the lacO array repositioning effects by 
replicates of the positives against negative controls. NETs with the 
strongest effects from figures 34 and 35 were retested in 2 additional experiments 
(50 cells scored in each repeat) and the results averaged. The repositioning effects 
of proteins tested were reproducible for both cell lines with p values < 0.0001 for the 
chromosome 5 cell line and p < 0.0322 for the chromosome 13 cell line. The p-
values represent the confidence that respective samples are different from the 
untransfected and the mRFP transfected controls as measured by the KS test. 
 
Since the chromosome repositioning effect could be indirect due to 
general chromatin distribution towards the nuclear periphery we scored the 
DAPI signal distribution in the samples with the repositioning effect and 




36). The rationale behind it is that if array reposition effects are due to 
general chromosome distribution towards the nuclear periphery then the 
DAPI intensity in these cells would be stronger in the peripheral shells than in 
the interior shells. For this analysis the algorithm from Figure 32 was 
modified to measure the DAPI intensity in each shell. Fifty cells were 
analyzed for each sample. The distribution of the DAPI signal did not alter in 
the samples with tethering effects (NET29, 39 and 47) when compared to the 
control mRFP samples in both cell lines meaning that the array repositioning 
effects are not due to general chromatin distribution towards the nuclear 
periphery.  
 
Figure 36. Chromosome repositioning effects caused by NETs are not 
due to general chromatin distribution towards the nuclear periphery. To 
test if the chromosome repositioning effects are due to general chromatin 
distribution towards the nuclear periphery the erosion algorithm from Figure 32 was 
adapted to measure the DAPI signal intensity in each shell. 50 samples for the 
tethering NETs (NETs 29, 39 and 47 in the chromosome 5 labelled cell line and 
NETs 29 and 39 in the chromosome 13 labelled cell line) were tested and no 
increase of the DAPI signal was observed at the nuclear periphery compared to the 
mRFP transfected control cells. The darkest blue bars represent the most peripheral 
shells with a gradient of lighter blue colours marking the more internal shells 
respectively. The DAPI intensity is presented in normalized arbitrary units. Note:The 
DAPI intensity decreases from the interior towards the periphery because the 




When performing the lacO array repositioning screen it was expected  
that when the lacO array repositions to the nuclear periphery then the lacO 
array-containing chromosome would also reposition together with the array 
since work from the Bickmore lab provided evidence for this (Finlan et al., 
2008). In order to affirm that the whole lacO array-containing chromosome is 
also relocating upon overexpression of particular NETs fluorescence in situ 
hybridization (FISH) was performed to label both the lacO array and the 
chromosome 5 simultaneously (Figure 37). In control cells expressing the 
NET37 the lacO array-containing chromosome localized to the nuclear 
interior (Figure 37 upper panel),  but in the NET39 expressing cells both the 
array and the chromosome localized to the nuclear periphery confirming that 
the array is moving together with the chromosome. Furthermore, it is 
important to note that in the case of NET39 both the array containing 
chromosome and the chromosome homologue without the array integration 
localize to the periphery suggesting that NET39 recruits chromosome 5 
independently of the lacO array (Figure 37 lower panel). This is also 
supported by the fact that in the NET39 expressing cell the lacO array itself is 
not right at the nuclear periphery whereas chromosome 5 is. 
 
Figure 37. Affirmation that the whole chromosome is moving to the 
nuclear periphery. Both the lacO array and chromosome 5 were visualized 
simultaneously by means of fluorescence in situ hybridization (FISH). In the NET37 
expressing cell both the array and the chromosome localize to the nuclear interior 
(upper panel) whereas in the NET39 expressing cell both array and chromosome 
are at the nuclear periphery (lower panel). Notably, both chromosome 5 copies are 
at the nuclear periphery, one that contains the lacO array and the other without the 





4.2 Recapitulation of NET-mediated chromosome 
tethering in cells lacking the lacO array and 
repositioning analysis of additional chromosomes 
To exclude repositioning effects due to possible NET-lacO array 
interactions HT1080 cell lines stably expressing the NETs but lacking the 
lacO array were generated. The NETs in those cells lines were fused to GFP 
because better antibodies are available for GFP than for mRFP11. FISH 
analysis on chromosome 5 in these cell lines confirmed the chromosome 
repositioning effects seen previously in the lacO cell lines (Figure 38). Cell 
lines stably expressing NET5, 29, 39 and 47 tended to have the chromosome 
5 at the nuclear periphery while cell lines expressing control proteins NET37 
and NET55 tended to have a more internal chromosome 5 localization.  
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Figure 38. Chromosome 5 repositioning towards the nuclear periphery 
is recapitulated in cells stably expressing the NETs but lacking the lacO 
array. Cells lacking the lacO array but stably expressing the NETs were tested for 
chromosome 5 position by FISH. Cells expressing NET5, 29, 39 and 47 have all 
revealed more peripheral chromosome 5 localization whereas NET37 and NET55 







To quantify the chromosome 5 repositioning effects in cells stably 
expressing the chromosome repositioning NETs the algorithm described in 
Figure 32 was modified to measure the total chromosome intensity in each 
erosion shell of the nucleus12. Furthermore, since chromosomes are much 
bigger than the lacO array, the two most peripheral and two most interior 
shells were fused and are referred to as periphery and interior, respectively 
(Figure 39, A). In two independent experiments the chromosome 5 positions 
were determined by means of this algorithm. Again, NET5, 29, 39 and 47 
revealed a more peripheral chromosome localization (~50-100% increase) 
compared to untransfected or GFP-NLS expressing control cells, while 
NET37 and NET55 had a similar chromosome 5 distribution as the 
untransfected and GFP-NLS transfected controls (Figure 39, B).  
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Figure 39. Quantification of Chromosome 5 repositioning in cells stably 
expressing NETs but lacking the lacO array. (A) The automated algorithm 
from Figure 32 was modified to measure the proportion of chromosome signal in 
each individual shell. Because the chromosomes occupy a much bigger area than 
the small lacO array the two most outer and two most inner shells were fused and 
called periphery and interior respectively. (B) Chromosome 5 localization was 
quantified in two individual experiments where a total of 100 cells were analyzed. 
NET5, 29, 39 and 47 all revealed a more peripheral localization of chromosome 5 
(~2-fold compared to controls), while untransfected and GFP-NLS transfected 
control cells as well as NET37 and NET55 stable cells made a more internal 
localization of chromosome 5 evident thus confirming the results in Figure 38. 
 
We tested if localization of additional chromosomes in respect to the 




HT1080 cell line. Further chromosomes tested were chromosome 1, 11, 13, 
17 and 19. For chromosome 13 the results from the lacO array visual screen 
were also recapitulated (Figure 40, A): NET29 and NET39 increased the 
incidence of this chromosome at the nuclear periphery (~1.2-fold) whereas 
upon NET47 expression this chromosome localized more internally (~2-fold) 
than in control samples (untransfected and GFP-NLS transfected cells). Also, 
like in the lacO screen, expression of NET5, 37 and 55 had no effect on the 
chromosome 13 localization.   
Next, the localization of chromosome 19 was assessed (Figure 40, B). 
This chromosome is known to occupy a more internal localization in 
interphase cells, which was confirmed in this study.  More than 80% of the 
chromosome signal was in the interior for all of the samples tested and none 
of the NETs was able to accumulate this chromosome at the nuclear 
periphery suggesting again that repositioning effects are chromosome 
specific. 
Locations of chromosomes 1, 11 and 17 were tested in the NET39 
and NET47 expressing cells and in GFP-NLS expressing control cells. For all 
these three chromosomes the effects were rather weak. NET39 and 47 
expressing cells displayed a more internal localization of chromosome 1 
(~10% decrease) compared to GFP-NLS expressing control cells (Figure 40, 
C). But both NET39 and NET47 revealed a more peripheral localization of 
chromosome 11 (~20% increase) compared to the GFP-NLS control (Figure 
40, D). Chromosome 17 was much more internal than chromosome 1 and 
11. Upon expression of NET 39 and NET47 its peripheral proportion 





Figure 40. Localization of chromosomes 1, 11, 13, 17 and 19 upon 
stable NET expression. Cells stably expressing the NETs and control cells were 
analyzed by FISH scoring 100 cells in total for each sample in two individual 
experiments. (A) NET29 and NET39 expressing cells revealed a more peripheral 
localization of chromosome 13 than cells expressing NET5, 37, 47, 55 or control 
cells (untransfected and GFP-NLS transfected cells). (B) Chromosome 19 was very 
internal in all samples and no NET altered its position into a more peripheral 
configuration. (C) Both NET39 and NET47 slightly decreased the localization of 
chromosome 1 from the nuclear periphery compared to GFP-NLS control cells. (D) 
and (E) NET39 and NET47 slightly increased the incidence of chromosomes 11 and 





Since the 2D algorithm does not reflect the total nuclear volume we 
developed an algorithm that is analyzing the chromosome position within the 
complete 3-dimensional nuclear volume. Unlike the 2D algorithm, which 
erodes the nuclear area, the 3D algorithm erodes the nuclear volume from 
3D reconstructions and scores the proportion of the chromosome in each 3D 
shell. Due to technical settings the 3D algorithm erodes the nuclear volume 
into 6 concentric 3D shells of roughly same volume13.  An example from such 
a 3D reconstruction of the nucleus together with one chromosome pair is 
shown in Figure 41 A. The sequence of an erosion is shown in Figure 42 B 
where the chromosomes are shown after each erosion step. 
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Figure 41. 3-dimensional (3D) erosion algorithm for determination of the 
spatial chromosome position. (A) 3D reconstruction of a nucleus with the 
chromosome from stacks. (B) The 3D algorithm erodes the reconstructed nuclear 
volume from the periphery to the interior into 6 concentric shells of roughly same 
volume. Erosion is shown stepwise shell by shell from left to right. The proportion of 
the chromosome is determined automatically by the algorithm in each individual 
shell. 
 
Five chromosomes (1, 5, 11, 13 and 17) were re-tested for their spatial 
localization upon individual NET expression using the 3D erosion algorithm 
(Figure 42). Like in the 2D erosion algorithm the two most peripheral and 
most internal shells were fused and are referred to as periphery and interior, 




analysis for each sample.  The results from the 2D erosion analysis were 
recapitulated. Cell lines expressing NET5, 29, 39 and 47 revealed a more 
peripheral localization of chromosome 5 (100-200% increase) compared to 
NET37, NET55 and the GFP-NLS control (Figure 42, A). NET29 and NET39 
increased the incidence of chromosome 13 at the periphery (50% increase) 
compared to the control and to the other NETs tested (Figure 42, B). NET39 
and 47 decreased (50% decrease) the peripheral localization of chromosome 
1 (Figure 42, C) but increased (50-100% increase) the incidence of 
chromosome 11 (Figure 42, D) and 17 (100-200% increase) (Figure 42, E) at 






Figure 42. 3D algorithm confirms the results of the 2D method. The 
algorithm eroding the 3D reconstructed nuclei and scoring for the chromosome 
proportion in each eroded shell was applied to test the 3D localization of 
chromosomes 1, 5, 11, 13 and 17. Twenty nuclei were analyzed for each sample 
and the results averaged. The most two inner and the two most outer shells were 
fused and named periphery and interior, respectively. (A) Similar to the 2D analysis 
NET5, 29, 39 and 47 revealed a more peripheral localization of chromosome 5 
compared to NET37, 55 and the controls (untransfected cells and GFP-NLS 
expressing cells). (B) NET29 and 39 expressing cells revealed a more peripheral 
chromosome 13 localization compared to the other NETs and the controls. Like in 
the 2D analysis NET47 decreased the chromosome 13 incidence at the periphery.  
(C) Chromosome 1 was less peripheral in NET39 and NET47 expressing cells 
compared to the GFP-NLS control. (D) and (E) Both NET39 and NET47 caused a 
more peripheral localization of chromosome 11 and 17 in comparison to the GFP-




4.3 NETs can precipitate a chromatin fraction and 
only full-length NETs can reposition chromosomes - 
Further proof of NET-mediated chromosome 
repositioning 
Though expression of some NETs resulted in the repositioning of 
some chromosomes to the nuclear periphery it was not clear if NETs can 
actually physically interact with chromatin. To test if NETs can bind chromatin 
a modified ChIP procedure was applied. GFP-fused NETs were precipitated 
after crosslinking with paraformaldehyde and then immuno-precipitated with 
an anti GFP antibody. The precipitate was probed for histone H3 as a 
general marker for chromatin. As a negative control NLS-GFP alone was 
used. Barrier-to-autointegration factor (BAF), a protein known to interact with 
chromatin was used as a positive control14. All NETs that caused 
chromosome 5 repositioning were able to precipitate the histone H3 whereas 
NET55, which did not reposition this chromosome, did not precipitate histone 
H3 (Figure 43). These results indicate that the NET-mediated effect of 
chromosome repositioning could be through a physical interaction with the 
chromosome. At this point, however, it is unclear whether the NET-chromatin 
interaction is direct or indirect.  
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Figure 43. Chromosome repositioning NETs can co-immunoprecipitate a 
chromatin fraction - NET-mediated repositioning of chromosomes is 
likely direct. Cell lines stably expressing chromosome 5 repositioning NETs were 
subject to a modified ChIP procedure where GFP-NETs were precipitated with an 
anti GFP antibody after cells were crosslinked. The precipitates were probed for 
histone H3 as marker for chromatin to test if NETs are able to precipitate chromatin. 
NLS-GFP alone was used as a negative control and BAF, a known chromatin 
protein served as a positive control. NET5, 29, 39 and 47 as well as BAF were all 
able to precipitate histone H3 whereas the GFP alone and NET55 were not. 
 
To further test if the tethering effect of NETs is direct or indirect stable 
cell lines expressing soluble fragments of the tethering NETs were generated 
(Figure 44). The rationale here is that if full-length NETs are modulating 
chromosome position though an enzymatic function or by initiating a 
signalling cascade then also soluble fragments of those NETs should 
reposition chromosomes to the nuclear periphery. However, if full-length 
NETs are robustly interacting with the chromosome to capture it at the 
nuclear periphery, then soluble fragments of these NETs would not be able to 





Figure 44. Soluble fragments of NETs that reposition chromosomes. (A) 
Soluble portions of NETs (blue) that were able to reposition chromosomes were 
cloned and fused to the classical SV40 NLS to ensure their nuclear localization. We 
designed two soluble constructs for NET5, because it contained two large soluble 
portions.  Dark grey boxes indicate membrane domains of the corresponding NETs. 
(B) The localization of depicted soluble constructs was tested by 
immunofluorescence. All fragments localized to the nucleus, as did the NLS-GFP 
control. 
 
To test if cells stably expressing the soluble fragments of NETs are 




soluble NET cell lines were subjected to quantification of the chromosome 5 
localization by the 2D algorithm (Figure 45). A total of 100 cells were 
analyzed for each sample. Soluble NET29 had comparable chromosome 5 
distribution patterns like the GFP-NLS control. For soluble NET39 and 
NET47 the chromosome localization tended to be slightly higher at the 
nuclear periphery compared to the control but the effect was not as striking 
as with full-length NET39 and NET47 (see Figure 39) suggesting that the 
chromosome repositioning to the periphery depends likely on direct 
interaction of the NET with the chromosome at the nuclear periphery rather 
than an enzymatic function of the NET. 
 
Figure 45. Soluble fragments of chromosome-tethering NETs fail to 
reposition chromosome 5 to the nuclear periphery. Soluble fragments of 
NETs 29, 39 and 47 were checked for their chromosome 5 localization to test if they 
can also cause a repositioning of the chromosome to the nuclear periphery like their 
full-length counterparts. A total of 100 cells were analyzed by the 2D algorithm for 
each sample.  None of the soluble fragments were able to increase the incidence of 
chromosome 5 at the NE to such a striking extend as their wild-types analogues. 
Chromosome 5 distribution for NET29 was very similar to the NLS-GFP control 
whereas both NET39 and NET47 had a very slight increase of the chromosome at 






4.4 Summary of chapter 4 
In this chapter I conducted a screen for NETs that can reposition 
chromosomes to the nuclear periphery. For this I initially used two cell lines in 
which chromosome 5 and 13 were visualized by a GFP labelled lacO array. 
These cell lines were transfected with RFP-fused NETs and the array-
containing chromosome position was determined by a computer algorithm. I 
found several NETs that were changing the position of the array-containing 
chromosome in respect to the nuclear periphery. Furthermore, I confirmed 
the chromosome repositioning results in cell lines lacking the lacO array and 
stably expressing GFP-tagged NETs. We further demonstrated that NETs 
can co-immunoprecipitate histone H3 as a general marker for chromatin. 
Together with the finding that soluble portions of chromosome-repositioning 
NETs were not able to tether chromosomes to the nuclear periphery this 
observation suggested that the NET-chromosome interaction could be direct 








Tissue-specific NETs can 
mediate a spatial chromosome 
positioning that correlates with 
that in tissues 
In previous studies some components of the NE were already shown 
to reposition chromosomes to and from the nuclear periphery. For example, a 
truncation mutant of the ubiquitously expressed lamin B1 in human cells was 
shown to cause repositioning of chromosome 18 from the nuclear periphery 
to the nuclear interior (Malhas et al., 2007). But since lamin B1 is a widely 
expressed protein it is unlikely to be a driver of tissue-specific chromosome 
positioning. We hypothesized that tissue-specific chromosome organization 
is likely to be mediated by proteins that are tissue-specific themselves. 
Therefore we tested the chromosome repositioning NETs whether they are 
preferentially expressed in particular tissues or not. For this we obtained and 
probed ready-to-use western blots containing several human tissues 
(Imgenex) with NET antibodies15 (Figure 46, A).  
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5.1 Chromosome repositioning NETs are tissue-
specific 
 
I will refer to NETs being tissue-specific even though some of them are 
preferentially expressed in more than one tissue. Thus the meaning of 
tissue-specific here indicates that a NET is expressed in only very few 
tissues out of the many tested. 
 
Indeed, in line with our hypothesis, all of the chromosome 
repositioning NETs were tissue-specific. NET5 had strong tissue preference 
for brain skeletal muscle and testis. Though the bands for NET5 were 
differently sized it can be explained by the presence of splice variants. 
NET29 has also several splice variants and was extremely liver-specific with 
detectable levels in brain and NET39 had extremely strong accumulation in 
brain, liver and muscle although moderate expression in heart, small intestine 
and kidney were also evident. Both NET45 and 47 were extremely liver-
specific and NET55 was relatively ubiquitously expressed throughout all 
tested tissues (Figure 46, A).  
We sought independent confirmation for NET tissue-specificity by 
using a publicly available transcriptome database (BioGPS), which is a 
microarray transcriptome comparison between more than 80 human tissues 
(Figure 46, B). Transcript levels of NET29, 39, 45, 47 and 55 were extracted 
from the database for adipose, bone marrow, heart, kidney, liver, lung, 
skeletal muscle, skin, small intestine and brain tissue. No data for NET5 were 
available in this database. The transcript levels for NETs were normalized 
against the median of more than 80 tissues sampled in the entire database. 
NET29 transcript levels were highest in heart, but were also high in liver. 
NET39 was preferentially expressed in heart tissue. NET45 was highly 




similar amounts in both liver and heart. NET55 confirmed ubiquitous 
expression throughout all tissues. Though the transcriptome database 
basically confirmed the tissue-specificity of the NETs there were also some 
differences compared to the protein level results (human tissue 
immunoblots). Those can be explained by factors like differences in stability 
of mRNA or difficulty in processing of the human tissue for RNA preparation 









Figure 46. NETs that reposition chromosomes are tissue-specific. (A) 
Human tissue western blots were probed with antibodies against NETs. NET5 has 
several splice variants (bands with different apparent molecular weights) and was 
preferentially expressed in brain, skeletal muscle and testis. NET29 protein levels 
were highest in liver and brain. Although strongly expressed in liver and skeletal 
muscle NET39 could also be detected in brain, heart, small intestine and kidney. 
NET45 and NET47 were extremely liver-specific and NET55 was widely expressed. 
(B) NET transcript levels were accessed from a transcriptome database (BioGPS) in 
particular tissues. Transcript levels are shown as fold-difference over median from a 
total of more than 80 tissues of the database. NET29 transcript levels were up in 
liver and heart. NET39 was heart specific. NET45 levels were highest in liver but 
were also high in the small intestine and NET47 was high in both liver and heart. 




5.2 Chromosome positioning correlates with tissue-
specificity of NETs 
To test the potential link between tissue-specific preferred positions of 
interphase chromosomes and the tissue-specific expression of NETs the 
chromosome 5 location was compared between human liver and kidney 
biopsy tissues. As shown in Figure 46 out of the NETs that repositioned 
chromosome 5 NET45 and NET47 were highly expressed in liver but none of 
them was expressed in kidney. Hence, together with the knowledge that all of 
the chromosome-tethering NETs were identified from liver tissue, we 
hypothesized that in liver, where these chromosome 5 tethering NETs are 
naturally up-regulated, chromosome 5 should be more at the periphery than 
in kidney, where none of these NETs are expressed. To test this hypothesis 
human tissue sections from liver and kidney tissue were obtained and 
subjected to FISH and quantitative analysis with the 2D erosion algorithm. 
Indeed, in liver16 chromosome 5 had a more peripheral localization than in 
kidney17 (Figure 47, A). Quantitative analysis of both tissues scoring 100 
cells in total confirmed this trend (Figure 47, B). 
 
Figure 47. Chromosome 5 is more peripheral in human liver than in 
kidney. Human biopsy liver and kidney tissues were stained for chromosome 5 by 
FISH. (A) In liver chromosome 5 had a more peripheral configuration than in kidney 
tissue. (B) Quantitative analysis scoring 100 cells in total for both tissues confirms 
the trend that chromosome 5 is more peripheral in liver than in kidney (p-value < 
0.01). 
                                                          
16
 Within the liver section hepatocytes, which comprise ~80% of the liver tissue, were imaged.  
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 Within the kidney section proximal and distal tubule cells and collecting duct cells of the renal 




5.3 NET-mediated tissue-specific chromosome 
positioning is reversible  
To further test if tissue-specific NETs could mediate tissue-specific 
spatial chromosome organizations we depleted two liver-specific NETs in the 
liver-derived cancer cell line HepG2. The rationale behind this is that if liver-
specific NET45 and 4718, both naturally expressed in this cell line, are 
tethering chromosome 5 to the nuclear periphery in these cells, then 
depletion of these NETs should result in the release of chromosome 5 from 
the nuclear periphery. By reducing the levels of these two proteins by means 
of RNAi (Figure 48) chromosome 5 should be released from the periphery at 
least partially since its tethering points at the periphery are reduced.  
 
Figure 48. Knockdown of liver-specific proteins NET45 and NET47 in 
HepG2 liver cells. (A) Semi-quantitative RT-PCR shows efficient transcript 
reduction for both NET45 and NET47 in HepG2 cells treated with NET45 and 
NET47 siRNA oligos compared to scramble siRNA oligo treated control cells. PPIA 
was used as a loading control. (B) Reduction of protein levels of NET45 and NET47 
is assessed by western blotting in cells treated with siRNA oligos against the two 
proteins. NET45 was detected with a NET45 antibody in HepG2 cells. NET47 was 
detected as a GFP fusion with an anti GFP antibody because the anti NET47 
antibody was not working on HepG2 lysates (even though it worked on the human 
tissue western blots). Porin was used as a loading control. 
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 from here on I will refer to NET47 being liver-specific because in human tissue western blots, i.e. on 
the protein level, it was highly expressed only in liver but in the transcriptome database, i.e. at the RNA 




After depletion of the liver-specific NETs 45 and 47 in HepG2 cells 
FISH was performed to test the chromosome 5 localization (Figure 49). In 
control cells chromosome 5 localized mainly to the nuclear periphery (Figure 
49, A left), however, in cells depleted for NET45 and NET47 the chromosome 
lost its peripheral localization in many cells (Figure 49, A right). This 
observation was confirmed when the chromosome 5 localization was 
quantified in both samples (Figure 49, B). Four days after siRNA treatment 
the peripheral localization of chromosome 5 was reduced with significant p-
values and this effect increased over time. 
 
Figure 49. Peripheral localization of chromosome 5 is reduced in HepG2 
liver cells depleted from liver-specific NET45 and NET47. (A) In scramble 
siRNA treated cells chromosome 5 localizes mainly to the nuclear periphery (left) 
but is found more internal in cells depleted from NET45 and NET47. (B) Quantitative 
analysis using the 2D erosion algorithm confirms the trend. Chromosome 5 
localization is significantly reduced in NET45 and NET47 depleted cells after 4 days 
of RNAi treatment compared to scramble oligo treated control cells. The reduced 





5.4 Summary of chapter 5 
In this chapter we analyzed the expression patterns of the 
chromosome-tethering NETs in human tissues and found that all of these 
NETs were highly tissue-specific with some of them being specific to liver. In 
line with this finding I found that chromosome 5 was more peripheral in liver 
than in kidney, a tissue in which most of tethering NETs were not expressed. 
Based on this finding we tested if depleting of two liver-specific proteins 
would release chromosome 5 from the nuclear periphery and indeed knock-












specific gene expression19 
 
6.1 NET-mediated chromosome repositioning affects 
global gene expression 
Spatial chromosome and gene repositioning has been linked with 
modulations of the respective gene activities. That is why having identified 
several novel tissue-specific nuclear proteins that can alter the position of 
chromosomes we searched for gene expression changes that have occurred 
in coherence with the chromosome repositioning. This was done by means of 
microarray analysis. Differentially expressed genes in HT1080 cells stably 
expressing chromosome-tethering NETs were normalized against the 
differentially expressed genes in the GFP-NLS cells. The normalized 
differentially expressed genes from the NET cell lines were then divided into 
two groups.  The first group represents all genes that were up-regulated 
(Figure 50, left) upon the overexpression of the according NET and the 
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 The bioinformatics gene expression analysis in this chapter was performed by Dr. Jose de las Heras 




second group shows all down-regulated genes (Figure 50, right) upon 
particular NET expression. Figure 50 represents those two groups in a Venn 
diagram with numbers of genes for each individual NET, which are specific to 
the NET and are shared with other NETs. Notably for both up- and down-
regulated genes is the high overlap between the NET29 and the NET39 cell 
line. On the contrary the overlap for NET5 and NET47 was minimal. This 
observation makes sense from the point of view that both NET29 and NET39 
had very similar chromosome repositioning patterns since both increased the 
incidence of chromosome 5 and 13 at the nuclear periphery whereas NET5 
and NET47 were tethering chromosome 5 to the NE but not chromosome 13. 
When looking at differentially expressed genes shared between all of the 
NETs the overlap was minimal suggesting differences in mechanisms of 
chromosome repositioning between the NETs. 
 
Figure 50. Up- and down-regulated genes in cell lines stably expressing 
the chromosome-repositioning NETs. The transcriptome of cells expressing 
the chromosome-repositioning NETs was assessed by microarrays and all genes 
that were changed in the according cell lines were clustered into two groups. The 
first group represents all genes that were up-regulated (left), the other group shows 
the number of genes that were down-regulated (right). Furthermore, the Venn 
diagram displays regulated genes, which were unique for each NET and those that 
were shared between the analyzed NET cell lines. NET29 and NET39 cell lines had 
a notable overlap of genes that were either up- or down-regulated. In contrast, the 
overlap between NET5 and NET47 was much smaller. The total overlap between all 
NET cell lines was moderate for both up- and down-regulated genes. 
To check if NET-mediated differential expression of genes would 




transcription profile of HepG2 cells upon knockdown of liver-specific proteins 
NET45 and NET47. The table below (Table 9) lists the 10 most down-
regulated genes upon the NET45 and NET47 knockdown. Indeed, of the 10 
most down-regulated genes seven were associated with liver function. 
 
Table 9. The ten most down-regulated genes upon knockdown of NET45 and 
NET47 in HepG2 liver cells are linked to liver function 
Rank Gene Function 
1 DAK NET45 
2 IGFBP1 Highly induced in LIVER regeneration 
3 ACOX2 LIVER metabolism 
4 APOM LIVER enriched, cholesterol transport 
5 LOX Crosslinks collagen in LIVER, cirrhosis 
6 SOAT2 LIVER enriched, fatty acid metabolism 
7 EGR1 Induced during LIVER regeneration 
8 SELM Perinuclear localization 
9 THAP4 Widely expressed 










6.2 Differentially expressed genes in NET cell lines 
partly overlap with gene changes in differentiation 
systems  
We further investigated if NET induced chromosome repositioning 
results in tissue-specific gene expression profiles. For this we compared the 
differentially expressed genes in the NET cell lines with genes up-regulated 
in a hepatic differentiation system. The transcriptome of a hepatic 
differentiation system was obtained from a public database 
(http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE14897) 
and plotted (differentiated vs. undifferentiated). On this plot we introduced a 
line to mark a threshold demarcating genes that were at least 2-fold up-
regulated during hepatic differentiation (all genes above the line). We then 
compared the differentially expressed genes of the NET cell lines with the 
hepatic differentiation system by overlaying the differentially expressed 
genes in the NET cell lines with the up-regulated genes in the hepatic 
differentiation system (Figure 51). Genes that were up-regulated in both, the 
NET cell lines and the hepatic differentiation system, were colour coded in 
red. Genes that were down-regulated in the NET cell lines but up-regulated in 
the hepatic differentiation system were colour coded in blue (enlarged blue 
spots).  
Many genes that were up-regulated in the cell line expressing the 
liver-specific protein NET47 were also up-regulated during hepatic 
differentiation (Figure 51, NET47). In contrast, the muscle- and heart-specific 
protein NET39 had very little overlap since most of genes that were up-
regulated during hepatic differentiation were down-regulated (Figure 51, 
NET39) in the NET39 stable cell line. NET29 that was relatively liver-specific 
(but not as much as NET47) had an intermediate overlap with the hepatic 
differentiation system (Figure 51, NET29). These data suggest that tissue-





Figure 51. Overlap with a hepatic differentiation system in up-regulated 
genes is strong for NET47, intermediate for NET29 and weak for NET39. 
Transcriptome data from a hepatic differentiation system was assessed and genes 
that were up- or down-regulated in the HT1080 cell lines stably expressing NET29, 
NET39 and NET47 were overlaid. Colour coded in red are genes that were up-
regulated in the NET expressing cell line and the enlarged blue colour coded spots 
are genes that are down-regulated in the stable NET cell line. When defining a 
confidence threshold for genes that were up-regulated in the hepatic differentiation 
system (red line) one can see that many genes that were up-regulated during 
hepatic differentiation were also up-regulated in the liver-specific NET47 expressing 
cell line. In contrast, for NET39, which is more muscle-specific, the overlap with the 
hepatic differentiation system is minimal as many genes that are up-regulated during 
hepatic differentiation are down-regulated in the NET39 cell line. NET29, which is 
expressed in both liver and heart, displays an intermediate overlap with the hepatic 
differentiation system.  
 
We further tested if differentially expressed genes in the NET cell lines 
are enriched for those involved in differentiation. For this we performed gene 
ontology analysis using the GOstats package (Bioconductor.org). We tested 
if functions associated with aspects of differentiation are enriched in the cell 
lines stably expressing the chromosome repositioning NETs 29, 39 and 47 
(Figure 52, NET samples) using the total genome (Figure 52, ALL) as a 
reference. Cell lines stably expressing the chromosome repositioning NETs 
displayed an enrichment of functions implicated in differentiation. This data 
suggests that overexpression of NETs can indeed cause an enrichment of 






Figure 52. Strong enrichment of differentially expressed genes 
associated with aspects of development and differentiation was 
observed in cells stably expressing chromosome repositioning NETs. 
The gene expression profiles of the NET cell lines were divided into GO-terms 
according to particular cell functions. The whole genome served as a control (ALL). 
Specific NET expression profiles revealed strong enrichment for genes implicated in 
differentiation with cellular functions such as cell migration and mobility, 
development and differentiation and growth and proliferation when compared to the 
whole genome control (ALL).  
 
6.3 Transcriptome changes mediated by the full-
length NETs are not recapitulated by their soluble 
fragments 
To investigate if NETs can alter gene expression only when they 
localize to the NE or if the soluble parts of NETs can also induce a specific 
expression pattern we have compared the expression profiles derived from 
cell lines expressing full length NETs and from cells expressing only the 
soluble NET domains (Figure 53). Genes that were up-regulated (compared 
to the GFP-NLS transfected control) were colour coded in red and genes 
down-regulated in blue. For the three NETs tested (NET47, NET39 and 
NET29) the soluble fragments could not recapitulate the expression patterns 





Figure 53. Stable cell lines of soluble NET fragments do not recapitulate 
gene changes caused by the full-length proteins. Expression profiles in 
cells expressing full-length chromosome-repositioning NETs were assessed and 
compared to the expression profiles of cells expressing only the soluble domains of 
the according NETs. The colour coded red spots represent genes that were up-
regulated and blue spots genes that were down-regulated in the NET cell lines 
compared to the GFP-NLS transfected control cells. Neither for NET47 nor for 
NET39 and NET29 could the expression profile of the soluble fragment recapitulate 
the expression profile of the full-length NET. 
 
6.4 Artificial versus NET-mediated chromosome 
repositioning 
The final interesting question to answer was if artificially mediated 
chromosome repositioning (for example using the lacO-lacI system) or NET-
mediated chromosome repositioning was necessary to induce changes in 
gene expression. To test this we compared the expression profiles of the 
chromosome-repositioning NETs with the expression profile of a cell line 
where a bacterial lacO array integrated into chromosome 5 and a lacI-LAP2 
construct was expressed simultaneously in order to artificially tether the 
chromosome 5 to the NE (Figure 54). When looking at genes that were 
uniquely regulated by the particular NETs then there was about 20-35% 
overlap with the lacI-LAP2 cell line (Figure 54, left). The overlap with the lacI-
LAP2 cell line increased to about 30-50% when total genes (not unique for 
particular NET) were compared. This data suggests that roughly two-thirds of 
genes are specifically altered by a particular NET and about one-third of 
altered genes are due to general effects of peripheral positioning. This 




by which the chromosome is repositioned have an impact on gene 
expression. 
 
Figure 54. Artificial chromosome 5 tethering mimics only partially the 
expression profile of chromosome tethering NET cell lines. Gene 
expression profiles of cells stably expressing NETs that are relocating chromosome 
5 to the NE and cells in which chromosome 5 was repositioned to the NE by a 
artificial high affinity tether were compared. The artificial high affinity tethering of 
chromosome 5 was accomplished through a lacO array integration into chromosome 
5 and simultaneous expression of lacI-LAP2. LacI has a high affinity to the lacO 
array, thus tethering the whole chromosome 5 to the nuclear periphery. When 
looking at genes that were uniquely changed upon NET overexpression around 20% 
of genes were shared with the lacI-LAP2 cell line for NET5, NET29 and NET39. 
NET47 shared around 40% of differentially expressed genes with the lacI-LAP2 cell 
line. When taking genes into account that were not unique in the NET expressing 
cell lines then the proportion of genes shared with the lacI-LAP2 cell line increased 










6.5 Summary of chapter 6 
After having found that tissue-specific NETs help to achieve a tissue-
specific chromosome patterning within the nucleus the next logical step was 
to test if specific gene expression patterns are established upon the up-
regulation of these chromosome-repositioning NETs. In this chapter the 
expression profiles were assessed by means of microarrays. We found that 
there was a general tendency towards down-regulation of genes supporting 
the general hypothesis that genes are silent at the NE. We observed a strong 
overlap of differentially expressed genes between the NET29 and the NET39 
samples coherent with the fact that both proteins had similar effects on 
chromosome positioning. When comparing all NETs together, the general 
overlap of differentially expressed genes was small suggesting different 
mechanisms at work.  
When I further knocked down liver-specific chromosome-tethering 
NETs 45 and 47 in HepG2 liver cells we observed that 7 out of the top 10 
down-regulated genes were related to liver function. This led us to compare 
the genes regulated by NETs with a hepatic differentiation system. We found 
that liver-specific NET47 had a strong overlap with the hepatic differentiation 
system while heart specific NET39 had only minimal overlap. NET29, which 
is expressed in both liver and heart, had an intermediate overlap with the 
hepatic differentiation system. These findings suggested a potential 
contribution of NETs to differentiation. Therefore we tested if differentially 
expressed genes in the NET cell lines could show enrichment for functions 
related to differentiation. Indeed this enrichment was observed. 
We also tested if expression profiles of cells expressing full-length 
NETs would match those expressing soluble NET portions, which were 
distributed throughout the nucleus and failed to recruit chromosomes to the 
nuclear periphery. We found no correlation suggesting that a particular gene 
expression profile can only be caused when the NET and its interacting 




Last we tested if artificial chromosome repositioning (using the lacO 
system) would match the gene expression profile of NET-mediated 
chromosome repositioning. For this we used a cell line that had a lacO 
integration on chromosome 5 and we tethered this chromosome by a lacI 
construct which was located at the NE. The gene expression profiles of this 
cell line were compared to the expression profiles of cell lines stably 
expressing the chromosome 5 tethering NETs. We discovered that though 
there was some overlap (~ 1/3) within these systems, the majority (~ 2/3) of 
the genes did not overlap. This suggested that the particular repositioning 
mechanism (most likely involving specific interaction partners) is dominant 









The present work provides the most comprehensive insight on 
transport of NETs to the INM to date and resolves a previous dispute 
showing that several mechanisms co-exist for INM protein translocation. The 
results presented here are in disagreement with the previously established 
hypothesis that NLSs are the main requirements for the use of the Ran-
dependent pathway. In fact, looking further our data suggests that a novel 
mechanism where FGs in NET sequences facilitate translocation into the 
INM is a much more commonly used pathway than the one involving Ran. 
Furthermore, while the debate of whether NETs translocate via the central or 
the peripheral channels of the NPC has just started, our data strongly argue 
for translocation through the peripheral channels. 
This work additionally describes a completely new layer of genome 
regulation from the NE that fuses chromosome positioning in a tissue-specific 
manner with regulation of gene expression. This fine-tuning mechanism is 
likely to optimize transcriptional regulatory cascades, for example in 
differentiation. This transcriptional optimization could occur by sequestering a 
transcriptional repressor together with the gene to be shut off at the 
predominantly silent environment of the nuclear periphery, thus achieving a 
more efficient silencing of the gene as the volume of the NE is about 1/40th of 
the total nuclear volume and the local concentration of the transcriptional 
repressor would therefore be dramatically increased. This mechanism would 
allow shutting off alternate differentiation pathways during commitment into a 




periphery together with a transcriptional activator could effectively enhance 
the concentration of the activator resulting in boosted transcription. 
Though we appreciate that transcription factors remain the major 
drivers of tissue-specific gene expression during differentiation, our findings 
advance the understanding of a mechanism by which a particular gene 
expression profile can be optimized by the spatial organization of 
chromosomes and the according genes located on them through tissue-
specific NETs. This hypothesis is supported by a recent study, which mapped 
the NE-chromatin interactions during differentiation of embryonic stem cells 
via neural precursor cells into astrocytes. This study was able to correlate the 
progressive differential expression of genes with their spatial repositioning 
from the NE (Peric-Hupkes et al., 2010). As shown in our study this 
repositioning can be mediated by the tissue-specific NETs, the variety of 
which is likely to match the release and capture of the plethora of genes 
during differentiation. 
 
7.1 What determines the steady state levels of NETs 
in FRAP and PA experiments? 
 NETs, like all membrane proteins are synthesized in the ER. To reach 
their actual functional destination, the INM, NETs have to move within the ER 
towards the ONM in order to finally translocate into the INM via the NPCs. 
The dynamic NET exchange between these cellular compartments creates 
several NET pools all of which determine the steady state levels of NETs in 

















The ER NET pool is constantly “fed” by nascent NET 
molecules, which are synthesized in the ER. NET molecules 
that do not have any interaction partners within the ER move 
without any directionality (a). Other NETs that do interact with 
other proteins within the ER could partly require ATP to form 
and break these interactions. Some of these NET interaction 
partners within the ER could be proteins that provide 
directionality (i.e. proteins of the licensing machinery) 










Some NETs of the ER-ONM pool have no directionality, thus 
these NET molecules can diffuse from the ER into the ONM 
or vice versa (c). This will not apply to NETs that are bound 
to licensing proteins, however, as their diffusion equilibrium 













The translocation pool should not have any directionality for 
NETs that move by free diffusion, thus these NETs should be 
able to translocate between the ONM and the INM in either 
direction (e). Directionality will only be provided to NETs that 
use Ran and the active classical nuclear transport machinery 
for translocation. That means, for example, that if these NETs 
are bound to Ran and potentially also import receptors they 








The INM NET pool is composed of two sub-pools. The first 
sub-pool harbours the minority of NETs, which are mobile in 
the INM. Consequently, this NET pool can either move within 
the INM (g) or even translocate back into the ONM. The 
second INM sub-pool harbours the majority of NET 
molecules. These NETs are highly immobile within the INM 
(h) because they are tightly bound to nuclear components in 
the nucleoplasm like lamins and chromatin. Thus their 
mobility depends on the abundance and strength of 
interactions with nucleoplasmic components. During the 
interaction the NET cannot move within the INM or 
translocate back into the ONM. 
 
 
 In this study I show that binding of NETs in the INM is very strong 




indicated that the fast fluorescence recovery in the NE in FRAP experiments 
depended stronger on exchange of NETs between ER and the INM rather 
than on movement of the NETs within the INM itself. This was also supported 
by the PA experiments where NETs photoactivated within the ER quickly 
accumulated in the NE. 
 Nevertheless, the corresponding contributions of the NET populations 
(table 10) to the measured mobilities during FRAP and PA experiments 
cannot be easily separated and therefore we applied computational modeling 
for ER-NE dynamics of 3 NETs (LAP1L, LAP2 and NET55) in an attempt to 
better understand the contributions of the pools to the steady state levels of 
NETs (Zuleger et al., 2011a; modeling performed by Dr. Andrew Goryachev, 
Centre for Systems Biology, Edinburgh, UK). The modeling took into account 
particular parameters such as mobilities of NETs in NE and ER FRAP 
experiments, mobilities during PA experiments in both the ER and the NE 
and the distribution of NETs between the ONM and INM (as determined by 
EM). The modeling was based on the assumption that NETs can freely 
diffuse between the NE and the ER in both directions (i.e. NETs that have 
particular translocation requirements such as ATP or Ran are not covered by 
the modeling20). 
 The mathematical ER-NE protein dynamics modeling also indicated 
that there is substantial exchange between the ER and the INM. In addition 
modeling suggested that differences in the FRAP t1/2s (Figure 14B) of NETs 
are not due to different times needed to traverse the NPC (according to the 
modeling the translocation kinetics of all three NETs were similar) but rather 
reflect their binding affinities in the INM. That means, for example, that the 
large t1/2 value of LAP1L can be explained by it having high affinity 
interactions in the INM while NET55 having a comparatively small t1/2 value 
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has interactions of lesser affinity within the INM compared to LAP1L. This 
finding is also supported by the literature as LAP1 is known to have many 
nucleoplasmic interactors (for review see Schirmer and Foisner, 2007), while 
NET55 has no known interactors in the nucleus to date.     
 Finally, the modeling further suggests that there is no directionality in 
the actual translocation step, meaning that once in the pore membrane (the 
membrane portion where the ONM fuses to the INM) NETs can equally 
translocate between the INM and the ONM. However, after the translocation 
step some NET molecules are entrapped in the INM due to interactions with 
lamins and/or chromatin components. The abundance of lamin- (~3x106 
lamin molecules in an average mammalian nucleus) and chromatin binding 
sites can never be saturated by NETs as even when overexpressed NETs 
are not likely to match the plethora of binding sites provided by the INM. 
 
7.2 Multiple independent mechanisms co-exist for 
translocation of NETs into the INM 
By directly comparing six NETs I was able to demonstrate that several 
distinct pathways co-exist whereas previous studies could not make this 
discrimination, because they only tested one or two proteins. 
Considering the wide range of characteristics among the NETs 
identified to date it logically follows that they are very likely to use different 
mechanisms for translocation dependent on their individual NET 
characteristics. The idea of several independent mechanisms is also 
supported by the involvement of different nucleoporins in NET translocation 
described to date (Antonin et al., 2011; Deng and Hochstrasser, 2006; King 
et al., 2006; Ohba et al., 2004; Theerthagiri et al., 2010). Although it should 
be noted that in most of the previous studies nucleoporins were simply 




translocation effects were simply due to disruption of the NPC structure (or 
just sterical blocking) rather than due to a specific interaction effect of the 
NET with the Nup. In our study, however, the Nup35 depletion effect seems 
specific since depletion of Nup35 only affects FG-containing proteins [Figure 
55, D; (Zuleger et al., 2011a)] and not other NETs. Furthermore, inferring 
from our data the previously proposed ATP- [Figure 55, B; (Ohba et al., 
2004)] and Ran-dependent [Figure 55, C; (King et al., 2006)] mechanisms 
are used by the minority of NETs tested and thus most NETs are likely to 
traverse the NPC barrier by either simple lateral diffusion [Figure 55, A; 
Soullam and Worman, 1993; Soullam and Worman, 1995)] or by yet 
undiscovered mechanisms.  
 Our finding that two out of six NETs tested (emerin and SUN2) require 
ATP also for their ER mobility argues that previous assumptions that ATP is 
required for the structural modification of the NPC structure to accommodate 
the translocating NETs (Ohba et al., 2004) might be incorrect. A more 
plausible explanation would be that ATP is needed for a potential chaperone 
step just prior to translocation in which ER partners are dissociated to reduce 
the complex mass and so enable translocation through the size-limited 
peripheral channels (Figure 55, B). In turn this would ultimately result in the 
reduction of NET mobility in the NE and this is exactly what was observed. In 
addition to the ATP requirement in the penultimate moment prior to 
translocation, ATP seems to be also needed in the ER at significant 
distances from sites of translocation. This could indicate a requirement for at 
least some NETs to bind and release partner proteins in the ER upon ATP 
hydrolysis. Indeed, emerin, a NET that was affected by ATP depletion in this 
study, has previously been shown to interact with tubulin in the cytoplasm 
(Salpingidou et al., 2007). Similarly, SUN2, the other NET affected by ATP 
depletion is a known interactor of Nesprins, which are membrane proteins 
that reside on the cytoplasmic face of the NE (Padmakumar et al., 2005; 




Additional interaction partners in the ER could be proteins of the INM protein 
sorting machinery residing in the ER, which were discovered by the 
Summers laboratory (Braunagel et al., 2007). Furthermore, also some NETs, 
such as the SUN proteins, have been shown to dimerize (Wang et al., 2006), 
thus ATP could be required in the ER to form and break interactions between 
the NETs themselves. 
It should be pointed out that inhibited mobility of NETs in the ER due 
to ATP depletion at significant distances from the site of translocation is very 
likely to ultimately also limit the rate of NET translocation into the INM. The 
depth of my data at this point, however, does not allow me to confidently 
deduce if the reduced translocation for emerin and SUN2 is due to inhibited 
mobility in the ER sites further away from sites of translocation or whether it 
is due to a ATP requirement in the penultimate moment prior to translocation 





Figure 55. Different mechanisms target NETs to the INM. (A) Proteins like 
NET51 translocate into the INM via the peripheral channels of the NPC by simple 
lateral diffusion. (B) Proteins like emerin and SUN2 require ATP for translocation 
into the INM. Since these proteins also require ATP for ER mobility we speculate 
that these proteins are bound to partner proteins and ATP is required to release 
emerin and SUN2 from this interaction prior to translocation via the peripheral 
channels of the NPC. (C) Of the NETs tested, only LBR was dependent on the Ran 
GTPase for translocation, indicating that use of classical NPC components is not as 
common as previously suggested. Nup35 appears to also be required for Ran-
mediated NET translocation. (D) Addition of FGs to the NET sequence facilitated 
translocation, indicating that a novel translocation mechanism exists. This 
mechanism also required Nup35 but was independent of the Ran-dependent 





7.3 The Ran-mediated mechanism is independent of 
NLSs  
In contradiction to previous suggestions (Lusk et al., 2007) NLSs are 
clearly not the determinants for the Ran-dependent pathway according to our 
data. Although our finding that LBR translocation requires Ran function is in 
line with previous observations indicating that Ran can bind LBR (Ma et al., 
2007) and importins are required for its licensing to translocate (Braunagel et 
al., 2007), the LBR-NLSs fused to other proteins did not show any Ran 
function dependence. 
In addition to LBR several other NETs in our study contained NLSs (as 
predicted by the pSORTII algorithm) but did not show any Ran dependence, 
further arguing that a NLSs is not a determinant of the Ran-mediated 
translocation pathway. However, it should be noted that one of the classical 
NLSs is principally a stretch of basic residues and since many NETs have 
basic residues in their nucleoplasmic domains to interact with DNA (Ulbert et 
al., 2006) these could be predicted erroneously as NLSs.  
Further support for a potential redundancy of NLSs for Ran-mediated 
INM protein targeting is provided by a recent study where an NLS on SUN2 
bound to importin-α and importin-β in a Ran-dependent manner, but mutation 
of the NLS did not inhibit targeting of SUN2 in interphase cells (Turgay et al., 
2010). Together with my finding that SUN2 targeting is not Ran-dependent, 








7.4 The FG-facilitated mechanism suggests that INM 
proteins can act as their own transport receptors  
 Since the discovery that transport receptors might interact with NETs 
to facilitate their translocation across the NPC (King et al., 2006) a question 
has puzzled the NE community: How could these huge NET-receptor 
complexes (only the receptor importin- is 97 kDa and often several 
receptors are bound to one cargo) be accommodated by the only 10 nm 
peripheral channels of the NPC, which in theory can fit a globular protein of 
only 60 kDa. Though a clear answer to this question cannot be given, and 
only translocation through the central channel seems possible in this case, 
my finding that FGs in NETs sequences can facilitate NET translocation into 
the INM suggests how this problem can be solved: NETs can act as their 
own transport receptors and thus facilitate their translocation through FGNET-
FGnucleoporin interactions just like it has been suggested for transport of soluble 
cargos where FGreceptor-FGnucleoporin interactions facilitate the import into the 
nucleus (Rexach and Blobel, 1995). In fact, our bioinformatic analysis of 199 
putative NETs shows a strong enrichment for FGs compared to mitochondrial 
membrane proteins arguing that this could be a general mechanism for INM 
protein transport. It should be noted, however, that the hypothesis that 
transport receptors mediate the transport of cargos into the nucleus through 
interaction of their FGs with FG-containing nucleoporins (Rexach and Blobel, 
1995) is lacking direct experimental proof. Still, our findings regarding the 
FGs and the observation that the FG-containing Nup35 is involved in NET 
transport support this model.     
When we found the accumulation of FGs in the LBR sequence we 
also noted that 4 out of the 6 FGs in the LBR sequence localize in or close to 
predicted transmembrane regions. This observation provides room for 
speculation that FG interactions between NETs and FG-Nups could not only 
occur in the peripheral channels but also in the membrane or the lumen. This 
idea is supported by the fact that GP210, a FG Nup that sticks from the 




the lumen, was found to be important for INM translocation of NETs (Ohba et 
al., 2004).   
Importantly, the FG-facilitated mechanism could not only apply to 
membrane proteins. Many soluble proteins do not have a predicted NLS, yet 
localize to the nucleus. Thus one could imagine that these cargos could 
translocate through the NPC via interactions of their own FGs with the FG-
Nups, just like suggested for the membrane proteins above. In fact this 
mechanism could be the preferred nuclear import pathway for many proteins 
lacking a NLSs. Therefore, future bioinformatic analyses should search large 
data sets of nuclear soluble and membrane proteins for whether there is a 
concentration of FGs in those that do not have predicted NLSs. 
 
 
7.5 What determines which pathway is utilized? 
The determinants driving the targeting by a particular mechanism still 
remain largely elusive but the use of a particular mechanism by a NET is 
most certain to depend on its particular properties. For example, in yeast the 
nucleoporin Nup170 is required for INM translocation of the NLS-containing 
NET Heh2 (King et al., 2006) but not for Doa10, which lacks an obvious NLS 
(Deng and Hochstrasser, 2006). The fact that testing for the same pathway 
while using different substrates and yielding different results really 
emphasizes that distinct determinants of NETs are likely to decide which 
translocation pathway to utilize. Supporting this idea, my study suggests that 
FGs in NETs are determinants of the FG-facilitated pathway.   
To comprehensively determine which specific NET characteristics are 
defining the usage of particular translocation pathways future studies need to 
test a large number of NETs with different characteristics for different 




large group of NETs that uses a particular translocation pathway is identified 
one can search for specific characteristics of this NET group that distinguish 
it clearly from another. 
 
7.6 Peripheral versus central channel translocation 
The use of the NPC central channel for transport of most soluble 
cargoes is undisputed, however the possibility that membrane proteins could 
also translocate through the central channel was deemed unlikely because it 
would involve doubtful scenarios of either extraction of the membrane protein 
from the membrane or the slicing of the translocating membrane protein 
through the NPC. Two recent studies however, claim exactly the latter 
(Meinema et al., 2011; Tapley et al., 2011). They suggest that the complex 
NPC structure is highly elastic and so the NET can reach through this 
structure while still being bound to the membrane on one end and being in 
the central channel of the NPC associated with transport receptors on the 
other end. Our data on the other hand, suggests the use of the NPC 
peripheral channels (Figure 56, right panel), since two transport mechanisms 
in our study, the Ran and the FG-facilitated pathway, both required Nup35 (in 
yeast Nup53p), a nucleoporin that resides in the peripheral channel of the 
yeast NPC according to a recently published high resolution map of the NPC 
(Alber et al., 2007). Another study, in mammalian cells, argues that Nup35 
interacts with lamins toward the nucleoplasmic face (Hawryluk-Gara et al., 
2005), but also this study would be consistent with Nup35 being in the 
peripheral rather than in the central channels of the NPC.  
Also previous studies, which increased the nucleoplasmic mass of a 
NET to more than 60 kDa (Ohba et al., 2004; Soullam and Worman, 1995), 
the size limit of the peripheral channels, and measured an inhibition of its 
translocation, support our results. If the NET would use the central channels 
for INM translocation, its size would be pretty much irrelevant since even the 




(Nissan et al., 2002). We also think that at least most of the NETs are using 
the peripheral channels as analysis from our lab on 199 predicted NETs 
shows that there is a clear size limit for NETs to have a nucleoplasmic 
domain of less than 60 kDa (Zuleger et al., 2011a), thus most of them would 
fit through the 60 kDa small peripheral channels.  
An argument that speaks for use of the central channel (Figure 56, 
right panel) is the discrepancy of the suggested binding to transport 
receptors, at least for some NETs, during translocation (Braunagel et al., 
2007; King et al., 2006; Meinema et al., 2011; Tapley et al., 2011; Turgay et 
al., 2010). Binding to these transport receptors would propel the NET 
nucleoplasmic mass to far more than 100 kDa, thus a translocation through 
the peripheral channels would only be possible when these channels 
changed shape to accommodate the large receptor-cargo complex.  
 
Figure 56. Are NETs using peripheral or central NPC channels to 
translocate into the INM? Two fundamentally distinct routes to reach the INM 
during interphase have been proposed for NETs: either through the peripheral NPC 
channels or though the central NPC channel aided by transport receptors (red). 
(Figure adapted from Antonin et al., 2011) 
Although even possible that some NETs translocate through the 
peripheral and others through the central channels, the latter scenario would 
not account for the vast majority of NETs. This can be inferred from our data 
where FGs are enriched in large NET datasets arguing for the use of the 




contain a NLS (Zuleger et al., 2011a), a requirement claimed to be necessary 
for transport through the central channels (Meinema et al., 2011). 
A thought to resolve the discrepancy of the central channel 
translocation paradigm is the possibility that the NLS-dependent binding of 
some NETs to transport receptors is occurring during mitosis and not in 
interphase. Several studies showing that some NETs are interacting with 
chromatin at the end of mitosis to enable the NE formation (Anderson and 
Hetzer, 2007; Anderson et al., 2009; Haraguchi et al., 2000) give space for 
that speculation. Thus these NETs might be “seeded” at the future INM with 
the help of bound transport receptors before the NE is formed (Figure 57). In 
this case size limitation, which plays a role during interphase, would be 
irrelevant. 
 
Figure 57. NETs that bind transport receptors could be “seeded” into 
the future INM during mitosis. Some NETs might be targeted to the future INM 
already during mitosis through binding to chromatin around which the NE is known 
to form. This process might involve interaction of transport receptors (red) with 





Clearly, future studies need to solve the dispute of whether the central 
or peripheral channels or even both are used simultaneously during 
interphase for NET INM targeting. The Veenhoff lab study implicated the use 
of the central channel by fusing both a central channel nucleoporin and a 
NET to protein fragments, which dimerize when the drug rapamycin is added. 
Doing this they were able to trap the NET construct at the NPC after adding 
the drug, assuming their NET is using the central channel for translocation 
(Meinema et al., 2011). However, it was not tested if trapping of the same 
NET could also be mediated in the peripheral channel by fusing one 
interaction fragment to one of the peripheral channel nucleoporins. If the NET 
is not trapped in the peripheral channels, this experiment would clearly 
demonstrate the specificity of the system and really prove the use of the 
central channels for at least some NETs. We are planning to do this 
experiment in future.  
Also, the idea of potential NET targeting to the future INM during 
mitosis upon help of transport receptors needs to be pursued. The Blobel 
study that initially found the need of transport receptors for NET targeting  
(King et al., 2006) used temperature sensitive yeast strains to conditionally 
deplete the transport receptors. Upon receptor depletion NETs did not 
localize to the INM anymore but NET INM localization was restored upon 
subsequent expression of the receptors. Now repeating the same 
experiment, while having the cells blocked in interphase, would answer if the 
receptor-mediated targeting occurs in interphase or mitosis. If NET targeting 
is not restored upon subsequent receptor expression during the interphase 
block, we would know that receptor-mediated NET targeting occurs indeed 






7.7 Tissue-specific NETs mediate chromosome 
repositioning 
Tissue-specific 3-dimensional arrangements of chromosomes within 
the interphase nucleus are considered to be relevant but the function and 
consequence of this chromosome patterning remains largely unknown.  
Previous studies reported that some chromosomes reposition during 
differentiation (Galiova et al., 2004; Kim et al., 2004; Kuroda et al., 2004; 
Szczerbal et al., 2009) but the players that drive that repositioning remained 
obscure. Our findings provide an explanation for how tissue-specific 
chromosome positioning can be achieved and why this mechanism has not 
been discovered yet: the proteins that drive these cell type-specific 
chromosome arrangements are themselves tissue-specific.  
Previously described NE-chromatin interactions involved ubiquitously 
expressed proteins [reviewed in (Mattout-Drubezki and Gruenbaum, 2003)]. 
These were mostly interactions with heterochromatin (Brown et al., 2008; 
Capelson et al., 2010; Kalverda et al., 2010; Makatsori et al., 2004; 
Pickersgill et al., 2006) or enzymes that add silencing marks (Somech et al., 
2005). These interactions give a reason for why heterochromatin is located at 
the nuclear periphery but do not explain the tissue-specific patterns of 
chromosome positioning in relation to the nuclear periphery. Truncation 
mutants of lamin B1 have been shown to abolish peripheral localization of 
chromosome 18 (Malhas et al., 2007) but even this observation cannot 
explain the tissue-specific chromosome patterning since lamin B1 is also a 
widely expressed protein. Instead, lamin B1 might be required for the 
targeting of a tissue-specific NET that has a high affinity for chromosome 18. 
This hypothesis is supported by a recent study where the cardiomyopathy 
causing E161K mutation in lamin A promotes the release of chromosome 13  
from the nuclear periphery while another mutation on lamin A, D596N, 
causing the same disease is not releasing chromosome 13 from the NE 
(Mewborn et al., 2010). This observation suggests that the chromosome 




interacting proteins like tissue-specific NETs. One such chromosome 13 
tethering partner would not bind to the E161K lamin A mutant and therefore 
chromosome 13 is released from the NE. However, when lamin A is mutated 
in a different area then this partner is still able to bind to lamin and therefore 
chromosome 13 is maintained at the nuclear periphery.   
Another study demonstrated that several other mutations in the LMNA 
gene caused a release of chromosome 13 and 18 from the nuclear periphery 
(Meaburn et al., 2007), but again, also lamin A is widely expressed in 
differentiated cells, thus a more tissue-specific binding partner of lamin A is 
likely to contribute to the release of these chromosomes from the NE. The 
idea of tissue-specific lamin binding partners is further supported by the fact 
that lamin mutations are not causing a chromosome repositioning in all cell 
types (Boyle et al., 2001; Meaburn et al., 2005). Future studies clearly need 
to answer the question of whether lamins are required for targeting of the 
novel tissue-specific NETs.  
Even though we favour the hypothesis that tissue-specific NETs are 
the major drivers of tissue-specific chromosome arrangements it is actually 
also possible that A-type and B-type lamins can be drivers. Lamins are 
encoded by three different genes LMNA, LMNB1 and LMNB2, all of which 
have several splice variants and the proportions of these proteins vary 
between cell-types (Broers et al., 1997). Also a study where different lamin 
sub-types were expressed in Xenopus oocytes revealed that lamin A 
assembles into a layer that is closer to the chromatin than the lamin B 
filament layer (Goldberg et al., 2008) implying a potential higher affinity of 
lamin A to chromatin proteins than lamin B. This scenario can be 
hypothesized as nobody has compared affinities of different lamins to same 
chromatin proteins. Thus the variety of lamin proteins, their proportions in 
each cell type and their potentially different affinities to chromatin proteins 





In addition, the combinatorial basis of lamins is also likely to impact 
differential targeting of different tissue-specific NETs. Distinct lamins could 
have different affinities to specific NETs, which in turn have preferences for 
particular chromosomes. This would result in a highly regulated cell type-
specific 3D chromosome arrangement. The sum of all these differential lamin 
and NET interactions could really be the reason for switching of threshold 
interactions with chromosomes and thus resulting in tether of a particular 
chromosome and not another.   
       
7.8 Direct versus indirect NET-chromosome 
interaction 
We show in this study that chromosome repositioning NETs can co-
precipitate a chromatin fraction but at this point we cannot distinguish 
whether NETs tether chromosomes via direct interactions to DNA or 
indirectly by binding to proteins which associate with DNA. It is clear that 
many NETs can interact with DNA directly (Cai et al., 2001; Caputo et al., 
2006), however, the vast majority of identified NET interactions involved 
chromatin or chromatin binding proteins [reviewed in (Zuleger et al., 2011b)]. 
Thus we propose that rather than binding to DNA directly, the chromosome 
repositioning NETs are binding to tissue-specific chromatin binders like 
transcription factors or transcriptional repressors, proteins that are tightly 
bound to particular chromosome sequences. This hypothesis is sustained by 
the previous findings that NETs can indeed bind transcriptional regulators 
(Haraguchi et al., 2004; Holaska et al., 2003; Holaska et al., 2006). 
This working model would outperform a model where for example 
general repetitive DNA sequences are directly bound by a NET, because it 
would prove more flexible as explained in the following example: If our tissue-
specific NETs were to reposition chromosomes to the NE by direct interaction 
with DNA sequences, then the affected chromosome would be at the NE 




chromosome only when a specific regulator is present at a particular point in 
development, such as a kinase or phosphatase, which would modify the NET 
to either tether or release a particular chromosome or a NET-interacting 
transcriptional regulator, which is tightly bound to regions of the respective 
chromosome, then the NET could be present at any time and would tether 
the chromosome only when the transcriptional regulator is bound to the 
chromosome sequences. In fact, this model would also work for ubiquitously 
expressed NETs, which have been shown to bind chromatin [reviewed in 
(Zuleger et al., 2011b)] as the specificity for the chromosome/chromosome 
region would be provided by the tissue-specific DNA-binding protein (Figure 
58, A). Though we favour the hypothesis mentioned above we cannot 
exclude a direct interaction of the chromosome-repositioning NETs found in 
this study and the respective chromosome. This possibility would be 
legitimate due to the fact that the NETs are tissue-specific. One could then 
imagine that a particular chromosome is in the nuclear interior but repositions 
to the NE only once a tissue-specific NET with a high affinity for this 
chromosome is expressed, for example during differentiation (Figure 58, B). 
A third possibility would involve a chromosome repositioning to the nuclear 
periphery by an interaction of a tissue-specific NET with a tissue-specific 
DNA binding protein, however in this scenario both proteins must be present 






Figure 58. Hypothetical models of chromosome repositioning. (A) In the 
undifferentiated cell lamins and non-tissue-specific NETs are expressed and the 
chromosome resides in the nuclear interior (left). Upon differentiation a tissue-
specific chromosome binding protein is expressed for which non-tissue-specific 
NETs/lamins have a high affinity for and thus the chromosome is repositioned 
towards the nuclear periphery (right). (B) In the undifferentiated cell the 
chromosome resides in the nuclear interior (left) but upon differentiation a tissue-
specific NET is expressed that has a high affinity to the chromosome, thus the 
chromosome is tethered to the NE (right). (C) The cell is committed to differentiation 
and tissue-specific NETs are already expressed and the chromosome resides in the 
nuclear interior (left). With progressing differentiation a tissue-specific chromosome 
binding protein is expressed, which the tissue-specific NET has a high affinity for. 




Though these direct or indirect NET-chromosome affinity interactions 
are likely to be weaker than that of the lacO system, having many 
chromosome-NET tethers distributed at different points the chromosome 
would likely generate a more powerful tether than having them concentrated 
on one point of the chromosome like in the lacO system, which was 
previously shown to be able to recruit chromosomes to the NE (Finlan et al., 
2008). Both models of direct and indirect NET interaction are consistent with 
my finding that in liver HepG2 cells chromosome 5 is partially lost from the 
nuclear periphery upon depletion of liver-specific NETs 45 and 47. Since the 
effect is not absolute it is likely that there are other additional NETs that 
contribute to the tether of chromosome 5 at the nuclear periphery and 
subsequently contribute to the generation of a specific chromosome 
positioning pattern (Figure 59). 
 
Figure 59. Simple model of chromosome position regulation by NETs. 
Upon expression of NETs that are tethering chromosome 5 the localization of this 
chromosome is secured at the nuclear periphery (left side). When the chromosome 
5 tethering proteins NET45 and NET47 are depleted by siRNA, for example, 
chromosome 5 is released more into the nuclear interior but not completely as some 
yet unidentified proteins might still capture parts of this chromosome at the NE (right 
side). Upon renewed up-regulation/overexpression of NET45 and NET47 





Independent of whether these NET-chromosome interactions are 
direct or indirect another aspect that could drive specificity is epigenetics. 
This possibility gets strong support from studies that have found many NETs 
to interact with epigenetic marks or enzymes that can modify chromatin (Chi 
et al., 2007; Guarda et al., 2009; Makatsori et al., 2004; Somech et al., 2005) 
thus a NETs preference for a chromosome could not only be determined by a 
particular sequence but also by a specific epigenetic code, although it should 
be noted that there is no evidence for a large disparity in epigenetic 
modifications of chromosomes to date. But to test this idea one could 
investigate the chromosome regions that were found to be temporarily at the 
NE differentiation of nerve cells (Peric-Hupkes et al., 2010) and test if their 
interaction with the NE correlates with a particular epigenetic state.  
 
7.9 Does chromosome repositioning occur in mitosis 
or interphase? 
In all of the studies where a chromosome was artificially tethered to 
the nuclear periphery by a high affinity mechanism (Finlan et al., 2008; 
Kumaran and Spector, 2008; Reddy et al., 2008), the chromosome tethering 
required the cells to go through a cell division. And although I have not tested 
in this study if NET-mediated chromosome repositioning actually requires 
mitosis, I do favour the hypothesis where mitosis precedes large-scale 
chromosome reorganization for the following reasons. The nucleus of the 
interphase cell is very crowded and chromosomes are comparatively large 
structures and trying to move a chromosome all the way form the interior to 
the periphery, a possible distance of several microns, would likely prove 
extremely difficult. In contrast, during mitosis the chromosomes are compact 
and the NE has broken down into vesicles21. These vesicles contain the 
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 To date it is not entirely clear which form the NE takes after breaking down in mitosis. Some studies 
suggest it breaks down into vesicles (Buch et al., 2009; Hetzer et al., 2001; Salpingidou et al., 2008), 




chromosome repositioning NETs and could therefore bind to chromosomes 
for which the NETs have preference for (Figure 60, A). From the end of 
mitosis into interphase, when the NE is reformed, the NETs would have 
positioned the particular chromosome at the nuclear periphery (Figure 60, B-
D).  Evidence for this hypothesis derives from earlier mentioned observations 
where distinct emerin and LBR vesicles bind to different portions of 
chromosomes during mitosis (Haraguchi et al., 2000). Additional support for 
this hypothesis derives from our laboratory where the chromosome 
repositioning effect in 3T3-L1 cells was much smaller two days after the cells 
were transfected with chromosome repositioning NETs compared to the 
repositioning effect three days post transfection (observations were made in 
our laboratory by Eric Schirmer and Gerlinde Otti, unpublished). The 
rationale would be that cells would have to go through one round of mitosis 
so that the transfected NET DNA could reach the nucleoplasm22. After about 
12 hours post transfection NET material is expressed. At this point, 
approximately 2d post transfection, the repositioning effects could already 
occur due to the presence of the NET but they did not. The strong 
chromosome repositioning effects were only observed after additional 24 
hours suggesting that an additional round of mitosis was required to initiate 




                                                                                                                                                                    
et al., 1997). Here I will assume that the NE breaks down into vesicles, although the interaction with the 
chromosome would be virtually the same for both NE breakdown possibilities 
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Figure 60. Speculative affinity mechanism to establish spatial 
chromosome organizational patterns. (A) The NE breaks down into ER/NE 
vesicles in mitosis. Distinct vesicles contain specific NE proteins (colored triangles). 
NETs of some vesicles bind to regions of specific condensed chromosomes. (B) 
The NE starts to reform from vesicles at the end of mitosis with some specific 
chromosomes still being attached to particular vesicles. (C) After the NE formation 
some chromosomes are trapped at the NE due to specific NETs that have a high 
affinity for these particular chromosomes. The chromosomes are still mainly 
condensed. (D) In interphase the chromosomes decondense completely and occupy 





Though the observations mentioned above indicate a requirement for 
mitosis there is a recent report that large-scale radial chromosome 
repositioning can occur in non-dividing cells (Mehta et al., 2010). Thus it is 
not entirely clear if large-scale radial chromosome arrangements are 
established in mitosis or interphase or even both and there is a need for 
future studies to clarify this. 
 
7.10 Changes in gene activity upon chromosome and 
gene repositioning  
If one chromosome is tethered to the nuclear periphery another 
chromosome must be released from the periphery to make space for the 
other. This can be inferred from our data where the DAPI signal in cells 
where chromosome tethering NETs were expressed did not alter from control 
cells meaning that chromosome repositioning is not a side effect of general 
distribution of chromatin towards the nuclear periphery but rather an equal re-
distribution of chromosomes. Therefore, apart from changes in gene 
expression that involve silencing through direct nuclear periphery association 
of the chromosomes I have tested, there are also likely to be repression of 
genes from other non-tested chromosomes that are tethered by the NETs 
and also up-regulation of genes from release of other chromosomes from the 
periphery and secondary changes due to some of the genes changing being 
transcriptional regulators themselves. And this is exactly what we 
encountered when analyzing the gene expression profiles of the NET cell 
lines, as we noticed up- and down-regulated genes not only on 
chromosomes we tested the position for. 
While we noticed these gene changes in cells overexpressing 
chromosome-tethering NETs, it is reasonable to assume that depletion of 
these NETs would result in changes as considerable. In fact many genes are 
misregulated in laminopathies, diseases that arise from mutations in NE 




explain this gene misregulation in laminopathies as targeting of many tissue-
specific chromosome-tethering NETs is likely to depend on lamin binding, 
which would be possibly abolished when the lamins are mutated as already 
shown for other NETs (Ellis et al., 1998; Fairley et al., 1999; Reichart et al., 
2004; Wheeler et al., 2007). This gene misregulation could thus be a 
consequence of a NET not tethering particular chromosomes when needed. 
Most genes tested previously have been found to reposition from the 
nuclear periphery into the nuclear interior upon their activation (Hewitt et al., 
2004; Kosak et al., 2002; Meister et al., 2010; Ragoczy et al., 2006; Williams 
et al., 2006; Yao et al., 2011). This type of repositioning may activate genes 
by moving them away from transcriptionally silent regions of heterochromatin, 
large proportions of which are lining the nuclear periphery of most 
differentiated cells. There is however significant variation in the amount of 
peripheral heterochromatin between different cell types (Milner, 1969) and 
therefore the gene positioning effect is also likely to vary from one cell type to 
another. It is therefore not surprising that even though most of the genes are 
activated upon their reposition from the NE into the nuclear interior others are 
activated at the nuclear periphery. For example, the PLP gene is activated at 
the NE during oligodendrocyte differentiation (Nielsen et al., 2002) and in 
other systems gene activation at the nuclear periphery was observed (Hewitt 
et al., 2004; Johnson et al., 2000; Park and De Boni, 1998).  
In our study, when looking at all genes changed in the NET-
overexpressing cell lines, we found a preference for silencing rather than 
activation. This is consistent with the general assumption that the NE is a 
preferentially silenced environment. But yet we have not determined whether 
the affected genes have actually altered their positions in respect to the 
nuclear periphery. Doing this, we will be able to correlate whether silencing 
really correlates with peripheral localization of the gene or, like in the few 
studies mentioned above, no repositioning of the genes occurs even upon 
change in its transcriptional activity. More importantly, determination of the 




summation of genes interacting with the nuclear periphery causes the 
according chromosome to move to the NE or if the chromosome is 
specifically tethered to the periphery and the according genes are just 
repositioning as a side-effect of it. In fact we anticipate that staining for both 
the chromosome that has been repositioned to the periphery and the affected 
genes that are located on this chromosome will be able to discriminate 
between the two scenarios mentioned above. For example, when all or at 
least most of the affected genes within the chromosome co-localize with the 
nuclear periphery, we can deduce that indeed these genes are the tether 
points and the chromosome relocates as a side effect of it. On the contrary if 
most genes are not co-localizing with the NE, but rather are distributed 
throughout the peripheral chromosome, then it follows that the affected 
genes are not the actual tether points and were repositioned along with the 
chromosome. 
In most of the published studies mentioned above the position of the 
gene-containing chromosome was not determined to answer if the gene 
positioning corresponded to the position of the chromosome (i.e. is the 
chromosome changing its radial position together with the gene located on 
this chromosome or is the gene changing its radial position without affecting 
the radial position of the chromosome). A few recent studies addressed this 
question, however, and found that the gene moved within or even beyond the 
chromosome territory while the chromosome itself did not alter its position 
with respect to the nuclear periphery (Morey et al., 2008; Szczerbal et al., 
2009). Nevertheless, in one of these studies that investigated the 
chromosome repositioning during adipogenesis, the FABP4 gene moved 
from the periphery to the nuclear interior together with the corresponding 
chromosome (Szczerbal et al., 2009). Though the total of these observations 
is not giving a clear answer of whether individual gene repositioning causes 
the repositioning of the chromosome or vice versa, it is very likely that the 
summation of NE interactions with many individual gene sequences is 




not. More gene and chromosome data sampling will be required in future to 
give a clear answer to this interesting question. 
 
7.11 Functional consequences of NET-mediated gene 
repositioning – tissue-specific genes are regulated  
Our finding that the transcriptional profile of the liver-specific NET47 
partly overlapped with that of a hepatic differentiation system supports the 
hypothesis that NET-mediated chromosome repositioning helps to establish 
tissue-specific gene expression patterns. This is supported by the fact that 
heart-specific NET39 had little overlap with the hepatic system and NET29, 
which is expressed in both heart and liver overlapped with the hepatic system 
to a level that was between that of NET47 and NET39. Even though we had 
a notable induction of tissue-specific genes upon ectopic expression of 
tissue-specific chromosome-tethering NETs in the HT1080 cell line one could 
imagine that the effect would be even greater when we used cells that are 
committed along a particular differentiation pathway, which the NETs are 
specific for. These cells would provide the tissue-specific NET interaction 
partners, which are not expressed in HT1080 cells. We are currently testing 
this by ectopically expressing tissue-specific NETs in differentiation systems 
and will investigate if more tissue-specific genes can be induced in these 
cells. I anticipate that in addition to getting better transcriptional correlations 
with differentiation paradigms these cells are also likely to provide the means 
of better separating the changes in differentiation from the positioning effects 
(for example by depleting the NET during the differentiation of the cell line). 
The hypothesis that NET-mediated chromosome positioning could 
help to optimize the gene expression of a tissue that the NET is specific for 
gains further support by our finding that upon depletion of liver-specific 
NET45 and NET47 in the liver HepG2 cell line many liver-specific genes 




optimize regulation of differentiation to the already known main drivers of 
differentiation like transcription factors.  
Our observation that soluble fragments of chromosome repositioning 
NETs do not tether chromosomes to the periphery like their full-length 
membrane integrated counterparts and the fact that gene expression profiles 
of the two do not match each other suggest also that tethering of the 
chromosome to the NE is important to induce gene activity changes and also 
excludes the possibility that NETs cause chromosome repositioning indirectly 
through signalling cascades.  
Even more important than the finding above, are our results of the 
comparison between NET-specific (chromosome 5 tethered by NET 
expression) and non-NET-specific (chromosome 5 tethered by lacO/lacI 
interaction) chromosome repositioning. These results indicate that bringing 
the chromosome to the nuclear periphery per se is not enough to induce a 
particular gene expression profile meaning that not only the positioning effect 
itself but also the specific mechanism by which a chromosome is positioned 
to the nuclear periphery is playing a crucial role.  
Though the plethora of molecular determinants for gene regulation 
involving NETs is yet to be discovered, several possibilities can be proposed. 
Based on studies that found that NE components, including several widely 
expressed NETs, can sequester transcriptional regulators [reviewed in 
(Heessen and Fornerod, 2007)] one can imagine following working models: 
An active gene would be silenced when tethered to the nuclear periphery by 
a NET because a transcriptional repressor is sequestered at the NE (Figure 
61, A left) or silencing would occur because the gene is tethered to the 
nuclear periphery and incorporated into the transcriptionally silent 
heterochromatin milieu at the NE (Figure 61, B). A third possibility would 
arise from the findings that widely expressed NETs can bind enzymes that 
can modify chromatin into a silent configuration (Guarda et al., 2009; Somech 
et al., 2005). The expression of a tissue-specific NET that has a high affinity 




gene would be silenced by the activity of the enzymes that add silencing 
marks to the gene (Figure 61, C). 
 
Figure 61. Possible mechanisms for gene regulation by the NE. (A) A 
widely expressed regulatory NET or lamin protein binds a transcriptional repressor 
to the nuclear periphery while a particular gene locus in the nuclear interior is 
transcriptionally active (left). Upon gradual expression of a tissue-specific NET with 
a high affinity for the gene, the locus moves to the NE where it is silenced due to the 
transcriptional repressor (right). (B) The gene is transcriptionally active in the interior 
(left) until a tissue-specific NET with a high affinity for this gene is expressed 
resulting in tethering of the gene to the nuclear periphery where it is silenced due to 
incorporation into heterochromatin (right). (C) The interior gene is transcriptionally 
active until a NET with a high affinity for it is expressed causing  a repositioning of 
the gene to the NE where it is silenced due to chromatin silencing enzymes (i.e. 
histone deacetylase) trapped a the nuclear periphery. (Figure adapted from Zuleger 




7.12 Final remarks 
This work provides an advance in both the field of membrane protein 
targeting and the field of chromosome organization. Having found that 
several independent mechanisms co-exist for INM protein targeting, my work 
solves the inconsistencies of previous studies, which have reported distinct 
mechanisms but did not distinguish whether these are independent from one 
another or all part of a global and unifying mechanism. The discovery of the 
novel NET translocation mechanism (FG-facilitated mechanism) also gives 
rise to the anticipation that more additional mechanisms could be discovered 
in future. Once we discover all pathways we can systematically test the 
translocation of all NETs and determine which exact NET characteristics are 
determining which pathway to utilize.    
As for the chromosome repositioning work, our finding that tissue-
specific nuclear membrane proteins can change global chromatin 
organization and consequently impact gene expression supports the 
existence of a new layer of gene regulation, where gene activity is coupled to 
radial positioning of chromosomes. We do not argue that this regulatory layer 
dominates over other more traditional gene regulatory mechanisms, for 
example those mediated by transcription factors or epigenetics. Rather this 
repositioning-mediated gene regulatory mechanism is likely to fine-tune gene 
regulation mediated by epigenetics and transcription factors. Future studies 
will have to determine the exact mechanisms by which such NET-mediated 
nuclear organization changes occur. The fact that tissue-specific NETs 
promote the expression of tissue-specific genes is clearly asking for future 
studies to use manipulative differentiation models or even whole model 
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